NO150758B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-PYRIDINIUM ALKAN AND XYLENE COMPOUNDS - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-PYRIDINIUM ALKAN AND XYLENE COMPOUNDS Download PDF

Info

Publication number
NO150758B
NO150758B NO823274A NO823274A NO150758B NO 150758 B NO150758 B NO 150758B NO 823274 A NO823274 A NO 823274A NO 823274 A NO823274 A NO 823274A NO 150758 B NO150758 B NO 150758B
Authority
NO
Norway
Prior art keywords
mol
pyridinium
bis
pyridine
acetonitrile
Prior art date
Application number
NO823274A
Other languages
Norwegian (no)
Other versions
NO150758C (en
NO823274L (en
Inventor
Denis Mahlon Bailey
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/734,729 external-priority patent/US4107313A/en
Publication of NO823274L publication Critical patent/NO823274L/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO150758B publication Critical patent/NO150758B/en
Publication of NO150758C publication Critical patent/NO150758C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Description

Foreliggende oppfinnelse angår fremstilling av terapeutisk aktive bis-(4-amino-l-pyridinium)alkan- og xylenforbindelser med terapeutisk aktivitet og med den generelle formel: The present invention relates to the preparation of therapeutically active bis-(4-amino-l-pyridinium)alkane and xylene compounds with therapeutic activity and with the general formula:

hvor Y er en rettkjedet alkylengruppe med 4-14 karbonatomer eller en p-xylengruppe; R er en alkylgruppe med 3-12 karbonatomer, cyklohexyl eller p-klorfenyl; og A er et anion; where Y is a straight-chain alkylene group of 4-14 carbon atoms or a p-xylene group; R is an alkyl group with 3-12 carbon atoms, cyclohexyl or p-chlorophenyl; and A is an anion;

m er 1 eller 3; n er 1 eller 2; x er 1, 2 eller 3; og (m).(2) = (n).(x); forutsatt at når R er p-klorfenyl, er Y m is 1 or 3; n is 1 or 2; x is 1, 2 or 3; and (m).(2) = (n).(x); provided that when R is p-chlorophenyl, Y is

en rettkjedet alkylengruppe med 6-14 karbonatomer, og når R a straight-chain alkylene group with 6-14 carbon atoms, and when R

er usubstituert cyklohexyl, er Y en alkylengruppe med 8-14 karbonatomer. is unsubstituted cyclohexyl, Y is an alkylene group of 8-14 carbon atoms.

Disse forbindelser kan brukes for bekjempelse av bakterier og sopp og er også aktive mot herpes-virus. These compounds can be used to combat bacteria and fungi and are also active against the herpes virus.

US-patent 3.055.902 beskriver en gruppe bis-(4-amino-l-pyri-dinium) alkaner som mellomprodukter for fremstilling av de tilsvarende bis-(4-amino-l-piperidino)alkaner som angis å ha bakteriostatiske og baktericide effekter. US patent 3,055,902 describes a group of bis-(4-amino-1-pyridinium)alkanes as intermediates for the preparation of the corresponding bis-(4-amino-1-piperidino)alkanes which are stated to have bacteriostatic and bactericidal effects .

W.C. Austin et al., J.Pharm.Pharmacol. 11, 80-93 (1959) beskriver 1,10-bis-(4-amino-l-pyridinium)decandijodid og 1,10-bis-(4-acetamido-l-pyridinium)decandijodid. Det er angitt at visse forbindelser i den store og sterkt varierende gruppe av kvaternære ammoniumforbindelser har aktivitet mot amøber, bakterier og snylteormer, men det er ikke gitt noen biologiske data for noen av de ovennevnte forbindelser. W.C. Austin et al., J. Pharm. Pharmacol. 11, 80-93 (1959) describes 1,10-bis-(4-amino-1-pyridinium)decanediiodide and 1,10-bis-(4-acetamido-1-pyridinium)decanediiodide. Certain compounds in the large and widely varying group of quaternary ammonium compounds have been reported to have activity against amoebae, bacteria and parasitic worms, but no biological data have been provided for any of the above compounds.

I formel I kan alkylengruppen Y for eksempel være: 1,4-butylen, 1,5-pentylen, 1,6-hexylen, 1,7-heptylen, 1,8-oktylen, 1,9-nonylen, 1,10-decylen, 1,11-undecylen, 1,12-dodecylen, 1,13-tridecylen eller 1,14-tetradecylen. In formula I, the alkylene group Y can be, for example: 1,4-butylene, 1,5-pentylene, 1,6-hexylene, 1,7-heptylene, 1,8-octylene, 1,9-nonylene, 1,10- decylene, 1,11-undecylene, 1,12-dodecylene, 1,13-tridecylene or 1,14-tetradecylene.

I formel I, hvor R er en rett eller forgrenet alkylgruppe med fra 3-12, fortrinnsvis 7-9 karbonatomer, kan gruppen f.eks. være: n-hexyl, n-heptyl, n-oktyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, 1-metylpentyl, 2,2-di-metylbutyl, 2-metylhexyl, 1,4-dimetylpentyl, 2-etylpentyl, 3-etylpentyl, 2-metylheptyl, 1- etylhexyl, 2-etylhexyl, 2-propylpentyl, 2-metyl-3-etylpentyl, 3-etylheptyl, 1,3,5-tri-metylhexyl, l,5-dimetyl-4-etyl-hexyl, 2- propylheptyl, 5-metyl-2-butylhexyl, 2-propyl-nonyl eller 2-butyloktyl. In formula I, where R is a straight or branched alkyl group with from 3-12, preferably 7-9 carbon atoms, the group can e.g. be: n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, 1-methylpentyl, 2,2-dimethylbutyl, 2-methylhexyl, 1,4- dimethylpentyl, 2-ethylpentyl, 3-ethylpentyl, 2-methylheptyl, 1-ethylhexyl, 2-ethylhexyl, 2-propylpentyl, 2-methyl-3-ethylpentyl, 3-ethylheptyl, 1,3,5-tri-methylhexyl, l, 5-dimethyl-4-ethylhexyl, 2-propylheptyl, 5-methyl-2-butylhexyl, 2-propyl-nonyl or 2-butyloctyl.

Når A i formel I er et anion, kan dette innbefatte anioner av både uorganiske og organiske syrer, f.eks. bromid, klorid, fluorid, jodid, sulfat, fosfat, nitrat, sulfamat, metansulfonat, etansulfonat, benzensulfonat, p-toluensulfonat, naftalen-sulfonat, naftalendisulfonat, cyklohexylsulfamat, acetat, tri-fluoracetat, malat, fumarat, succinat, tartrat, oksalat, citrat, laktat, gluconat, askorbat, laktat, ftalat, salicylat, benzoat, pikrat, metanfosfonat, arsenitt, arsenat, tiosulfat, perklorat, tartronat, sarcosinat, N-lauroylsarcosinat, monofluorfosfat, hexafluoraluminat, hexafluorsilikat, hexafluorstannat, fluorzirconat, tetrafluorborat, hexaklorplatinat, tetraklor-aluminat, hexaklorstannat. Bromid og klorid er foretrukket. When A in formula I is an anion, this may include anions of both inorganic and organic acids, e.g. bromide, chloride, fluoride, iodide, sulfate, phosphate, nitrate, sulfamate, methanesulfonate, ethanesulfonate, benzenesulfonate, p-toluenesulfonate, naphthalene sulfonate, naphthalene disulfonate, cyclohexylsulfamate, acetate, trifluoroacetate, malate, fumarate, succinate, tartrate, oxalate, citrate, lactate, gluconate, ascorbate, lactate, phthalate, salicylate, benzoate, picrate, methanephosphonate, arsenite, arsenate, thiosulfate, perchlorate, tartronate, sarcosinate, N-lauroyl sarcosinate, monofluorophosphate, hexafluoroaluminate, hexafluorosilicate, hexafluorostannate, fluorozirconate, tetrafluoroborate, hexachloroplatinate, tetrachloroaluminate, hexachlorostannate. Bromide and chloride are preferred.

Ifølge foreliggende oppfinnelse fremstilles forbindelsene med formel I ved at man omsetter to mol av en 4-(R-amino)pyridin-forbindelse med formelen: According to the present invention, the compounds of formula I are prepared by reacting two moles of a 4-(R-amino)pyridine compound with the formula:

hvor R har den ovenfor angitte betydning, med et mol av en disubstituert alkanforbindelse med formelen: hvor Y har den ovenfor angitte betydning, og Z er klor, brom, jod, metansulfonyloksy, etansulfonyloksy, benzensulfonyloksy eller p-toluensulfonyloksyd, eller med et mol av en a, a'-disubstituert p-xylenforbindelse med formelen: hvor Z har den ovenfor angitte betydning, hvor A i den resulterende forbindelse med formel I tilsvarer gruppen Z, og - om ønsket - erstatning av Z-gruppen med et annet ønsket anion av A. En forbindelse med gunstig virkning og som derfor foretrekkes er 1,10-bis-[4-(oktyl-amino)-l-pyridinium]dekandibromid eller -diklorid. Denne forbindelse oppnås ved at man omsetter to mol av en forbindelse med formel III, hvor R er n-oktyl med et mol av en forbindelse med formel IV, hvor Y er en rettkjedet alkylengruppe med 10 karbonatomer og Z har den ovenfor angitte betydning. where R has the above meaning, with one mole of a disubstituted alkane compound of the formula: where Y has the above meaning, and Z is chlorine, bromine, iodine, methanesulfonyloxy, ethanesulfonyloxy, benzenesulfonyloxy or p-toluenesulfonyloxide, or with one mole of an α, α'-disubstituted p-xylene compound of the formula: where Z has the meaning given above, where A in the resulting compound of formula I corresponds to the group Z, and - if desired - replacement of the Z group by another desired anion of A. A compound with beneficial action and which is therefore preferred is 1,10-bis-[4-(octyl-amino)-1-pyridinium]decanedibromide or dichloride. This compound is obtained by reacting two moles of a compound of formula III, where R is n-octyl with one mole of a compound of formula IV, where Y is a straight-chain alkylene group with 10 carbon atoms and Z has the above meaning.

Omsetningen av forbindelse III med forbindelse IV eller V foretas hensiktsmessig i et inert oppløsningsmiddel, slik som en lavere-alkanol, acetonitril, N,N-dimetylformamid, N,N-di-metylacetamid, benzen, toluen, xylen og lignende, ved temperaturen i området 80-150°C i tidsrom på 1-24 timer. Vanligvis vil reaktantene bli oppvarmet ved 60°-100°C i acetonitril eller N,N-dimetylformamid eller en blanding av disse oppløs-ningsmidler eller i en lavere-alkanol i et tidsrom fra 2-20 timer. The reaction of compound III with compound IV or V is suitably carried out in an inert solvent, such as a lower alkanol, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, benzene, toluene, xylene and the like, at the temperature of the range 80-150°C for a period of 1-24 hours. Usually the reactants will be heated at 60°-100°C in acetonitrile or N,N-dimethylformamide or a mixture of these solvents or in a lower alkanol for a period of 2-20 hours.

Alternativt kan reaksjonen utføres i fravær av et oppløsnings-middel ved å oppvarme støkiometriske mengder av reaktantene ved temperaturer på 120-150°C i fra 2-5 timer. Alternatively, the reaction can be carried out in the absence of a solvent by heating stoichiometric amounts of the reactants at temperatures of 120-150°C for from 2-5 hours.

De resulterende bis-[4-(R-amino)-l-pyridinium]-forbindelser kan isoleres på vanlig måte, f.eks. ved filtrering, hvis produktet er uoppløselig i reaksjonsmediet, eller ved å fortynne reaksjonsblandingen med et ikke-polart oppløsningsmiddel såsom eter, benzen eller hexan for derved å få utfelt produktet, eller ved å fordampe reaksjonsmediet slik at man får produktet som en rest. Det resulterende råprodukt kan renses ved ut-krystallisering fra et egnet oppløsningsmiddel i nærvær av et absorbsjonsmiddel, f.eks. trekull eller diatomé-jord. The resulting bis-[4-(R-amino)-1-pyridinium] compounds can be isolated in the usual way, e.g. by filtration, if the product is insoluble in the reaction medium, or by diluting the reaction mixture with a non-polar solvent such as ether, benzene or hexane to thereby precipitate the product, or by evaporating the reaction medium so that the product is obtained as a residue. The resulting crude product can be purified by crystallization from a suitable solvent in the presence of an absorbent, e.g. charcoal or diatomaceous earth.

Bis-[4-(R-amino)-l-pyridinium]-forbindelse fremstilt slik det er angitt ovenfor vil selvsagt inneholde et anion (A i formel I) som tilsvarer den avspaltende gruppe i det disubstituerte alkan eller xylen (Z i formel IV og V). Bis-[4-(R-amino)-1-pyridinium] compound prepared as indicated above will of course contain an anion (A in formula I) corresponding to the leaving group in the disubstituted alkane or xylene (Z in formula IV and V).

Imidlertid kan aniongruppen i disse forbindelser varieres, However, the anion group in these compounds can be varied,

hvis dette er ønskelig, på vanlig måte, f.eks. ved å føre en oppløsning av en pyridiniumforbindelse i et egnet oppløsnings-middel som metanol, etanol eller vann, gjennom et sjikt av syntetisk ioneutbytningsharpiks inneholdende det ønskede anion. Oppløsningsmidlet kan så fordampes, og den resulterende pyridiniumforbindelse inneholdende det ønskede anion kan så renses ved omkrystallisering fra et egnet oppløsningsmiddel. if this is desired, in the usual way, e.g. by passing a solution of a pyridinium compound in a suitable solvent such as methanol, ethanol or water, through a layer of synthetic ion exchange resin containing the desired anion. The solvent can then be evaporated, and the resulting pyridinium compound containing the desired anion can then be purified by recrystallization from a suitable solvent.

Alternativt kan en pyridiniumforbindelse omsettes med et oppløselig salt inneholdende det ønskede anion i forbindelse med et motkation som kombinerer seg med anionet i pyridiniumforbindelsen slik at man får fremstilt et uoppløselig bunnfall. Dette kan så ufekilles, idet man da får en oppløsning av pyridiniumforbindelsen inneholdende det ønskede anion. For eksempel kan et bis-[4-(R-amino)-1-pyridinium]alkandihalogenid omsettes med sølvsaltet av en organisk eller uorganisk syre. Alternatively, a pyridinium compound can be reacted with a soluble salt containing the desired anion in connection with a counter cation which combines with the anion in the pyridinium compound so that an insoluble precipitate is produced. This can then be removed, as a solution of the pyridinium compound containing the desired anion is then obtained. For example, a bis-[4-(R-amino)-1-pyridinium]alkane dihalide can be reacted with the silver salt of an organic or inorganic acid.

Det utfelte sølvhalogenid fjernes, hvorved man får en oppløs-ning av pyridiniumforbindelsen inneholdende det ønskede organiske eller uorganiske anion. The precipitated silver halide is removed, whereby a solution of the pyridinium compound containing the desired organic or inorganic anion is obtained.

Den ovennevnte type av metatesereaksjoner kan også brukes for The above type of metathesis reactions can also be used for

å fremstille uoppløselige pyridiniumforbindelser. Således kan en oppløselig bis-[4-(R-amino)-1-pyridinium]-forbindelse omsettes med et oppløselig salt inneholdende det ønskede anion to prepare insoluble pyridinium compounds. Thus, a soluble bis-[4-(R-amino)-1-pyridinium] compound can be reacted with a soluble salt containing the desired anion

som kombinerer seg med pyridiniumkationet, hvorved man får det ønskede produkt som et uoppløselig bunnfall. Slike uopp-løselige pyridiniumsalter kan være hensiktsmessige for å få én god isolering og rensing, og kan egnet opparbeides i emulsjoner, kremer, pastaer, salver eller pulvere, og kan også brukes som depot-preparater for å gi en langsom og forsinket frigjøring av pyridiniumforbindelsen. which combines with the pyridinium cation, whereby the desired product is obtained as an insoluble precipitate. Such insoluble pyridinium salts can be suitable for good isolation and purification, and can be suitably processed into emulsions, creams, pastes, ointments or powders, and can also be used as depot preparations to provide a slow and delayed release of the pyridinium compound .

Skulle således aniondelen av en gitt forbindelse ha visse uønskede egenskaper slik som oppløselighet, stabilitet, mole-kylvekt, fysisk utseende, toksisitet eller lignende, så kan denne forbindelse lett omdannes til en annen og mer egnet form. For bruk på hud og annet vev eller i munnhulen, vil man selvsagt anvende farmasøytisk akseptable anioner som fluorid, klorid, bromid, jodid, metansulfonat og lignende. Thus, should the anion part of a given compound have certain undesirable properties such as solubility, stability, molecular weight, physical appearance, toxicity or the like, this compound can easily be converted into another and more suitable form. For use on skin and other tissues or in the oral cavity, one will of course use pharmaceutically acceptable anions such as fluoride, chloride, bromide, iodide, methanesulfonate and the like.

De 4-(R-amino)pyridiner (formel III) som brukes som utgangsforbindelser er genert kjente, og hvis de er ny - kan de fremstilles ved de fremgangsmåter som er angitt for fremstillingen av de kjente forbindelser. The 4-(R-amino)pyridines (formula III) which are used as starting compounds are generally known, and if they are new - they can be prepared by the methods indicated for the preparation of the known compounds.

Hensiktsmessig kan nevnte 4-(R-amino)pyridiner fremstilles Appropriately, said 4-(R-amino)pyridines can be prepared

ved å omsette 4-klor eller 4-brompyridin eller N-(4-pyridyl)-pyridiniumkloridhydroklorid med et passende substituert amin. Reaksjonen utføres vanligvis ved å oppvarme reaktantene i et fravær av et oppløsningsmiddel ved 150-225°C i tidsrom 1 1/2-3 timer. Produktet kan isoleres på vanlig måte, f.eks. ved ekstraksjon fra alkalisk vandig medium over i et organisk opp-løsningsmiddel som eter, metylenklorid eller kloroform, hvoretter man fordamper det organiske oppløsningsmiddel og utkry-stalliserer resten fra et passende oppløsningsmiddel. by reacting 4-chloro or 4-bromopyridine or N-(4-pyridyl)-pyridinium chloride hydrochloride with an appropriately substituted amine. The reaction is usually carried out by heating the reactants in the absence of a solvent at 150-225°C for 1 1/2-3 hours. The product can be insulated in the usual way, e.g. by extraction from an alkaline aqueous medium into an organic solvent such as ether, methylene chloride or chloroform, after which the organic solvent is evaporated and the residue crystallized from a suitable solvent.

Alternativt kan 4-(R-amino)pyridiner som oppnås ved katalytisk hydrogenering av en blanding inneholdende 4-aminopyridin og en karbonylforbindelse inneholdende et passende karboninnhold. Reaksjonen utføres vanligvis ved temperaturer på 50-70°C i et egnet oppløsningsmiddel, f.eks. etanol, under et hydrogentrykk på 1,5-4,5 kg/cm i nærvær av en palladium-hydrogeneringskataly-sator. Vanligvis vil en hydrogeneringstid på 4-10 timer være tilfredsstillende. Bruken av et stort overskudd av karbonyl-forbindelsen, f.eks. 200% eller større, vil fordelaktig gi høyere utbytte av et rent produkt i en reaksjonstid på 5 timer eller mindre. Etter at man har fjernet katalysatoren kan produktet isoleres ved fordampning av oppløsningsmidlet og enten destillere resten eller utkrystallisere den fra et egnet opp-løsningsmiddel . Alternatively, 4-(R-amino)pyridines obtained by catalytic hydrogenation of a mixture containing 4-aminopyridine and a carbonyl compound containing a suitable carbon content. The reaction is usually carried out at temperatures of 50-70°C in a suitable solvent, e.g. ethanol, under a hydrogen pressure of 1.5-4.5 kg/cm in the presence of a palladium hydrogenation catalyst. Usually, a hydrogenation time of 4-10 hours will be satisfactory. The use of a large excess of the carbonyl compound, e.g. 200% or greater will advantageously give a higher yield of a pure product in a reaction time of 5 hours or less. After the catalyst has been removed, the product can be isolated by evaporating the solvent and either distilling the residue or crystallising it from a suitable solvent.

Reaksjonen mellom et aldehyd med et passende karboninnhold The reaction between an aldehyde with a suitable carbon content

med 4-aminopyridin i nærvær av maursyre ved forhøyet temperatur, gir også 4-(R-amino)pyridiner. with 4-aminopyridine in the presence of formic acid at elevated temp., also gives 4-(R-amino)pyridines.

4-(R-amino)pyridiner kan også fremstilles ved å acylere 4-amino-pyridin med et acylhalogenid med passende karboninnhold, hvoretter man reduserer det resulterende amid. Acyleringen ut-føres på vanlig måte, f.eks. å omsette 4-aminopyridin med et acylhalogenid i et inert oppløsningsmiddel slik som metylen-diklorid eller kloroform i nærvær av en syreakseptor, f.eks. trietylamin. Det fremstilte amid blir så redusert med et kom-plekst metallhydrid, f.eks. litiumhydrid i et egnet oppløs-ningsmiddel som f.eks. tetrahydrofuran, eter eller dioksan, og aminproduktet kan sioleres på vanlig kjent måte. 4-(R-amino)pyridines can also be prepared by acylating 4-amino-pyridine with an acyl halide of suitable carbon content, after which reducing the resulting amide. The acylation is carried out in the usual way, e.g. reacting 4-aminopyridine with an acyl halide in an inert solvent such as methylene dichloride or chloroform in the presence of an acid acceptor, e.g. triethylamine. The produced amide is then reduced with a complex metal hydride, e.g. lithium hydride in a suitable solvent such as e.g. tetrahydrofuran, ether or dioxane, and the amine product can be isolated in a conventional manner.

Disubstituerte alkaner med formel IV som brukes som utgangs-materialer er vanligvis kjente, eller hvis de ikke er det, kan de fremstilles ved fremgangsmåter som er kjent for å fremstille de kjente forbindelser. Disubstituted alkanes of formula IV used as starting materials are usually known, or if they are not, they can be prepared by methods known to prepare the known compounds.

a,a'-disubstituerte xylener med formel V som også kan brukes som utgangsforbindelser, er generelt kjente forbindelser, α,α'-disubstituted xylenes of formula V which can also be used as starting compounds are generally known compounds,

eller hvis ikke så kan de fremstilles ved hjelp av kjente fremgang småter. or if not then they can be produced using known advances.

Således kan en passende klor- eller metyl-substituert tereftal-syre eller ester reduseres til det tilsvarende xylen-a,a'-diol med et metallhydrid slik som litiumaluminiumhydrid i et egnet oppløsningsmiddel som tetrahydrofuran, eter eller dioksan. Thus, a suitable chloro- or methyl-substituted terephthalic acid or ester can be reduced to the corresponding xylene-α,α'-diol with a metal hydride such as lithium aluminum hydride in a suitable solvent such as tetrahydrofuran, ether or dioxane.

Den fremstilte xylen-a,a'-diol kan så omdannes til en a,a'-dihaloksylen f.eks. ved reaksjon med hydrogenbromid, fosfor-tribromid, fosforoksyklorid, tionylklorid eller kaliumjodid eller ortofosforsyre ved hjelp av kjente fremgangsmåter. Alternativt kan xylen-a,a<1->diolen omdannes til en sulfonatester ved en reaksjon med metan, etan, benzen eller p-toluensulfonyl-klorid i nærvær av en syreakseptor som f.eks. pyridin, noe som skjer ved hjelp av kjente fremgangsmåter. The produced xylene-a,a'-diol can then be converted into an a,a'-dihaloxylene, e.g. by reaction with hydrogen bromide, phosphorus tribromide, phosphorus oxychloride, thionyl chloride or potassium iodide or orthophosphoric acid using known methods. Alternatively, the xylene-α,α<1->diol can be converted into a sulfonate ester by a reaction with methane, ethane, benzene or p-toluenesulfonyl chloride in the presence of an acid acceptor such as e.g. pyridine, which occurs using known methods.

Som mer detaljert beskrevet i det etterfølgende vil forbindelser med formel I ha in vitro antimikrobiell aktivitet mot flere typer mikroorganismer av den type som innbefatter både gram-positive og gram-negative bakterier, videre mot mange typer sopp og Herpes-virus. Forbindelsene kan således opparbeides i egnede farmasøytiske fortynningsmidler for å behandle infeksjoner som skyldes bakterier, sopp eller Herpes-virus, f.eks. i form av salver eller kremer eller lignende ved at de opparbeides i vanlige basisstoffer for slike preparater, f.eks. alkylpolyeteralkoholer, cetylalkohol, stearylalkohol og lignende, eller som pulvere ved at de tilsettes vanlige pulver-stoffer som stivelse, talkum eller lignende, eller gele preparater ved at de tilsettes vanlige geléstoffer som glycerol og tragant. De kan også bearbeides for bruk i aerosoler eller i skummidler. As described in more detail below, compounds of formula I will have in vitro antimicrobial activity against several types of microorganisms of the type that include both gram-positive and gram-negative bacteria, further against many types of fungi and Herpes virus. The compounds can thus be worked up in suitable pharmaceutical diluents to treat infections caused by bacteria, fungi or Herpes virus, e.g. in the form of ointments or creams or the like by being processed into common base substances for such preparations, e.g. alkyl polyether alcohols, cetyl alcohol, stearyl alcohol and the like, or as powders by adding common powder substances such as starch, talc or the like, or gel preparations by adding common gel substances such as glycerol and tragacanth. They can also be processed for use in aerosols or in foaming agents.

Molekylstrukturen på de fremstilte forbindelser ble fastslått på basis av studier over deres infrarøde og kjernemagnetiske spektra, og bekreftet ved en overensstemmelse mellom beregnede og funne verdier for de tilstedeværende elementer. The molecular structure of the prepared compounds was established on the basis of studies of their infrared and nuclear magnetic spectra, and confirmed by a correspondence between calculated and found values for the elements present.

Følgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.

Eksempel 1 Example 1

A. En blanding inneholdende 13 0 g (0,67 mol) 4-brom-pyridinhydroklorid og 152 g (1,0 mol) n-heptylaminhydroklorid ble oppvarmet på et oljebad. Da badtemperaturen nådde 180-185°C,begynte reaksjonsblandingen å smelte, og man begynte om-røring. Ved 190-195°C var smeltingen ferdig, og den flytende blanding ble omrørt ved 210-220°C i 2,5 timer. Den ble så avkjølt til romtemperatur, og det resulterende faste stoff ble oppløst i vann, gjort alkalisk med 35% vandig natriumhydroksyd, og produktet ble ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Den resulterende viskøse olje ble fortynnet med en liten mengde n-hexan og av-kjølt, hvorved man fikk et fast stoff som ble oppsamlet ved filtrering og tørket, og man fikk 86,6 g 4-(heptylamino)-pyridin, smp. 4 9-51°C. A. A mixture containing 130 g (0.67 mol) of 4-bromopyridine hydrochloride and 152 g (1.0 mol) of n-heptylamine hydrochloride was heated on an oil bath. When the bath temperature reached 180-185°C, the reaction mixture began to melt, and stirring began. At 190-195°C the melting was complete, and the liquid mixture was stirred at 210-220°C for 2.5 hours. It was then cooled to room temperature, and the resulting solid was dissolved in water, made alkaline with 35% aqueous sodium hydroxide, and the product was extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The resulting viscous oil was diluted with a small amount of n-hexane and cooled to give a solid which was collected by filtration and dried to give 86.6 g of 4-(heptylamino)pyridine, m.p. 4 9-51°C.

B. Alternativt kan 4-(heptylamino)pyridin fremstilles på følgende måte: En blanding inneholdende 229 g (1,0 mol) N-(4-pyridyl)pyridiniumkloridhydroklorid og 228 g (1,5 mol) n-heptylaminhydroklorid ble oppvarmet i 2 timer på et oljebad ved 215°C. Reaksjonsblandingen ble avkjølt til 8 0°C, fortynnet med isvann, gjot alkalisk med 35% vandig natriumhydroksyd og ekstrahert suksessivt med eter og kloroform. De organiske ekstrakter ble kombinert og fordampet til tørrhet under redusert trykk. Den resulterende viskøse olje ble oppløst i eter, og eteroppløsningen ble vasket med vann. Det vandige vaske-vann ble tilbakeekstrahert med kloroform, og kloroform-ekstraktet ble kombinert med eteroppløsningen. De samlede organiske oppløsninger ble tørket over vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Ved å avkjøle den gjenværende olje til -78°C fikk man en delvis stivning. B. Alternatively, 4-(heptylamino)pyridine can be prepared as follows: A mixture containing 229 g (1.0 mol) of N-(4-pyridyl)pyridinium chloride hydrochloride and 228 g (1.5 mol) of n-heptylamine hydrochloride was heated for 2 hours in an oil bath at 215°C. The reaction mixture was cooled to 80°C, diluted with ice water, made alkaline with 35% aqueous sodium hydroxide and extracted successively with ether and chloroform. The organic extracts were combined and evaporated to dryness under reduced pressure. The resulting viscous oil was dissolved in ether, and the ether solution was washed with water. The aqueous wash was back-extracted with chloroform, and the chloroform extract was combined with the ether solution. The combined organic solutions were dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. By cooling the remaining oil to -78°C, a partial solidification was obtained.

Det halvstive stoff ble fortynnet med en mindre mengde eter og filtrert. Man fikk derved et fast stoff som ble oppløst i en blanding av acetonitril og kloroform, og den resulterende opp-løsning ble behandlet med avfargende karbon, filtrert, og filtratet ble fordampet til tørrhet under redusert trykk. Det resulterende halvfaste stoff ble fortynnet med en mindre mengde eter og avkjølt. Man fikk således et fast stoff som ble oppsamlet ved filtrering og vasket med et lite volum kald eter, The semi-solid was diluted with a small amount of ether and filtered. A solid was thereby obtained which was dissolved in a mixture of acetonitrile and chloroform, and the resulting solution was treated with decolorizing carbon, filtered, and the filtrate was evaporated to dryness under reduced pressure. The resulting semi-solid was diluted with a small amount of ether and cooled. A solid was thus obtained which was collected by filtration and washed with a small volume of cold ether,

og etter tørking fikk man 84,6 g 4-(heptylamino)pyridin, and after drying, 84.6 g of 4-(heptylamino)pyridine were obtained,

smp. 50-52°C. m.p. 50-52°C.

C. 4-(heptylamino)pyridin ble også fremstilt ved å hydrogenere en blanding inneholdende 4-aminopyridin og hept-aldehyd slik det er beskrevet i Eks. 10B i det etterfølgende. D. En omrørt varm oppløsning inneholdende 10,0 g (0,052 mol) 4-(heptylamino)pyridin i 40 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 9,3 g (0,026 mol) 1,14-dibromtetradecan i 230 ml acetonitril, og blandingen ble så kokt i 20 timer under tilbakeløp. Det produktet som utfelte seg ved avkjøling av reaksjonsblandingen til romtemperatur, ble oppsamlet ved filtrering, vasket med kald acetonitril og tørket, hvorved man fikk 13,9 g 1,14-bis-[4-(heptylamino)-1-pyridinium]tetradecandibromi, smp. 88-90°C. C. 4-(heptylamino)pyridine was also prepared by hydrogenating a mixture containing 4-aminopyridine and heptaldehyde as described in Ex. 10B in what follows. D. A stirred hot solution containing 10.0 g (0.052 mol) 4-(heptylamino)pyridine in 40 mL acetonitrile was added dropwise to a solution containing 9.3 g (0.026 mol) 1,14-dibromotetradecane in 230 mL acetonitrile, and the mixture was then refluxed for 20 hours. The product which precipitated on cooling the reaction mixture to room temperature was collected by filtration, washed with cold acetonitrile and dried, whereby 13.9 g of 1,14-bis-[4-(heptylamino)-1-pyridinium]tetradecanedibromium was obtained, m.p. 88-90°C.

Eksempel 2 Example 2

En oppløsning inneholdende 5,0 g 1,14-[4-(heptylamino)-1-pyridinium]tetradecandibromid i 5,0 ml metanol ble tilsatt toppen av en kolonne med en diameter på 7,5 cm og som inne-holdt 500 ml syntetisk anionutbytningsharpiks i kloridformen "Amberlite IRA 400", pakket i metanol og ble så eluert med fire 125 ml's porsjoner med metanol. Det samlede eluat ble fordampet til tørrhet under redusert trykk, og den gjenværende olje ble oppløst i etanol, behandlet med avfargende karbon og fordampet til tørrhet. Det resulterende faste stoff ble behandlet med eter inneholdende et par dråper acetonitril, oppsamlet ved filtrering og tørket over forsforpentoksyd under vakuum, hvorved man fikk 3,94 g 1,14-bis-[4-(heptylamino)-1-pyridinium] tetradecandiklorid, smp. 113-116°C. A solution containing 5.0 g of 1,14-[4-(heptylamino)-1-pyridinium]tetradecanediobromide in 5.0 ml of methanol was added to the top of a 7.5 cm diameter column containing 500 ml synthetic anion exchange resin in the chloride form "Amberlite IRA 400", packed in methanol and then eluted with four 125 ml portions of methanol. The combined eluate was evaporated to dryness under reduced pressure, and the remaining oil was dissolved in ethanol, treated with decolorizing carbon and evaporated to dryness. The resulting solid was treated with ether containing a few drops of acetonitrile, collected by filtration and dried over phosphorus pentoxide under vacuum to give 3.94 g of 1,14-bis-[4-(heptylamino)-1-pyridinium] tetradecanedichloride, m.p. 113-116°C.

Eksempel 3 Example 3

En omrørt suspensjon inneholdende 11,54 g (0,06 mol) 4-(heptyl-amino) pyridin i 75 ml acetonitril ble kokt under tilbakeløp inntil man fikk en klar og homogen oppløsning. Den klare opp-løsning ble så dråpevis tilsatt en varm oppløsning inneholdende 9,84 g (0,03 mol) 1,12-dibromdocedan i 75 ml acetonitril. Etter at tilsetningen var ferdig ble koking under tilbakeløp fortsatt i 18 timer. Etter avkjøling til romtemperatur ble reaksjonsblandingen fordampet til tørrhet under redusert trykk. Det gjenværende faste stoff ble utrørt i eter, oppsamlet ved filtrering og tørket 48 timer i vakuum ved 60°C, A stirred suspension containing 11.54 g (0.06 mol) of 4-(heptyl-amino)pyridine in 75 ml of acetonitrile was refluxed until a clear and homogeneous solution was obtained. The clear solution was then added dropwise to a hot solution containing 9.84 g (0.03 mol) of 1,12-dibromodocedane in 75 ml of acetonitrile. After the addition was finished, refluxing was continued for 18 hours. After cooling to room temperature, the reaction mixture was evaporated to dryness under reduced pressure. The remaining solid was stirred in ether, collected by filtration and dried for 48 hours in vacuum at 60°C,

og man fikk 21,1 g 1,12-bis-[4-(heptylamino)-1-pyridinium] dod' ecandibromid,smp. 101-103 oC. and 21.1 g of 1,12-bis-[4-(heptylamino)-1-pyridinium] dod' ecanidibromide were obtained, m.p. 101-103 oC.

Eksempel 4 Example 4

A. En oppløsning inneholdende 6,6 g 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecandibromid i 25 ml metanol A. A solution containing 6.6 g of 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecane dibromide in 25 ml of methanol

ble satt til toppen av en kolonne med en diameter på 7,5 cm og pakket med 1 liter syntetisk anionutbytningsharpiks i kloridformen "Amberlite IRA 400" i metanol og langsomt eluert med 100 ml's porsjoner av metanol inntil man oppsamlet 700 ml eluat. Det samlede eluat ble fordampet til tørrhet under redusert trykk ved 2 5°C. Det resulterende gummiaktige stoff ble flere ganger behandlet med en 6:1 blanding av eter og acetonitril og så tørket under vakuum, hvorved man fikk 5,0 g 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecandiklorid, smp. 109-112°C. was added to the top of a 7.5 cm diameter column and packed with 1 liter of synthetic anion exchange resin in the chloride form "Amberlite IRA 400" in methanol and slowly eluted with 100 ml portions of methanol until 700 ml of eluate was collected. The combined eluate was evaporated to dryness under reduced pressure at 25°C. The resulting gummy substance was treated several times with a 6:1 mixture of ether and acetonitrile and then dried under vacuum to give 5.0 g of 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecanedichloride, m.p. 109-112°C.

B. Alternativt kan en blanding inneholdende 76,8 g (0,4 mol) 4-(heptylamino)pyridin og 4 7,8 g (0,2 mol) 1,12-diklordodecan holdes oppvarmet i 4 timer ved 125-130°C. B. Alternatively, a mixture containing 76.8 g (0.4 mol) 4-(heptylamino)pyridine and 4 7.8 g (0.2 mol) 1,12-dichlorododecane can be heated for 4 hours at 125-130° C.

Etter svak avkjøling ble 300 ml acetonitril tilsatt, og den resulterende blanding oppvarmet på et dampbad for å få en fullstendig oppløsning og så lagret i et kjøleskap over natten. Det utfelte produkt ble oppsamlet ved filtrering, vasket med kald acetonitril og eter, og det hygroskopiske produkt ble umiddelbart tørket under vakuum, hvorved man fikk 112 g 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecandiklorid, smp. 112-115°C. After slight cooling, 300 ml of acetonitrile was added, and the resulting mixture was heated on a steam bath to obtain complete dissolution and then stored in a refrigerator overnight. The precipitated product was collected by filtration, washed with cold acetonitrile and ether, and the hygroscopic product was immediately dried under vacuum, whereby 112 g of 1,12-bis-[4-(heptylamino)-1-pyridinium]dodecanedichloride, m.p. . 112-115°C.

Eksempel 5 Example 5

A. En blanding inneholdende 100 g (0,51 mol) 4-brom-pyridinhydroklorid og 110 g (0,8 mol) n-hexylaminhydroklorid ble oppvarmet på et oljebad. Da badtemperaturen nådde 175-180°C, begynte reaksjonsblandingen å smelte og omrøring ble begynt. Temperaturen ble så hevet til 227°C og omrøring fortsatte i 3,5 timer. Etter avkjøling til romtemperatur ble blandingen oppløst i varmt vann, den resulterende oppløsning ble avkjølt med is, gjort alkalisk med fortynnet vandig natriumhydroksyd og ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat og fordampet til tørr-het under redusert trykk. Resten ble behandlet med eter og avkjølt. Det resulterende faste stoff ble oppsamlet ved filtrering og vasket med kald eter. Fordampning av filtratet ga et annet utbytte av faststoff. De faste stoffer ble kombinert, oppløst i kloroform, behandlet med avfargende karbon og filtrert. Filtratet ble fordampet under redusert trykk, og resten ble behandlet med kal eter. Det således oppnådde produkt ble oppsamlet ved filtrering, vasket med kald eter og tørket, hvorved man fikk 63,6 g 4-(hexylamino)-pyridin, smp. 66-68°C. Fordampning av filtratet ga ytterligere 7,0 g med et smp. på 65-67°C. A. A mixture containing 100 g (0.51 mol) of 4-bromopyridine hydrochloride and 110 g (0.8 mol) of n-hexylamine hydrochloride was heated on an oil bath. When the bath temperature reached 175-180°C, the reaction mixture began to melt and stirring was begun. The temperature was then raised to 227°C and stirring continued for 3.5 hours. After cooling to room temperature, the mixture was dissolved in hot water, the resulting solution was cooled with ice, made alkaline with dilute aqueous sodium hydroxide and extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The residue was treated with ether and cooled. The resulting solid was collected by filtration and washed with cold ether. Evaporation of the filtrate gave another yield of solid. The solids were combined, dissolved in chloroform, treated with decolorizing carbon and filtered. The filtrate was evaporated under reduced pressure and the residue was treated with cal ether. The product thus obtained was collected by filtration, washed with cold ether and dried, thereby obtaining 63.6 g of 4-(hexylamino)-pyridine, m.p. 66-68°C. Evaporation of the filtrate gave a further 7.0 g with a m.p. at 65-67°C.

B. Alternativt kan 4-(hexylamino)pyridin fremstilles på følgende måte: En blanding inneholdende 229 g (1 mol) N-(4-pyridyl)pyridiniumkloridhydroklorid og 207 g (1,5 mol) n-hexylaminhydroklorid ble omrørt og holdt oppvarmet i 1,75 timer ved 175-185°C. Reaksjonsblandingen ble avkjølt og fortynnet med 750 ml isvann. Den resulterende oppløsning ble gjort alkalisk med 35% vandig natriumhydroksyd og etter fortynning med 1 liter vann ble den ekstrahert med eter og deretter med diklormetan. De organiske ekstrakter ble kombinert, tørket over vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Resten ble utkrystallisert fra eter, gjenoppløst i kloroform, og oppløsningen ble behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under redusert trykk og resten ble behandlet med en kald eter slik at man fikk 71,0 g 4-(hexylamino)pyridin, smp. 68-70°C. C. En omrørt varm oppløsning inneholdende 10,7 g (0,06 mol)4-(hexylamino)pyridin i 50 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 10,7 g (0,03 mol) 1,14-dibromtetradecan i 250 ml acetonitril, og den resulterende blanding ble kokt i 22 timer under tilbakeløp. Reaksjonsblandingen ble så fordampet til tørrhet under redusert trykk. B. Alternatively, 4-(hexylamino)pyridine can be prepared as follows: A mixture containing 229 g (1 mol) of N-(4-pyridyl)pyridinium chloride hydrochloride and 207 g (1.5 mol) of n-hexylamine hydrochloride was stirred and kept warm in 1.75 hours at 175-185°C. The reaction mixture was cooled and diluted with 750 ml of ice water. The resulting solution was made alkaline with 35% aqueous sodium hydroxide and after dilution with 1 liter of water was extracted with ether and then with dichloromethane. The organic extracts were combined, dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The residue was crystallized from ether, redissolved in chloroform, and the solution treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under reduced pressure and the residue was treated with cold ether to give 71.0 g of 4-(hexylamino)pyridine, m.p. 68-70°C. C. A stirred hot solution containing 10.7 g (0.06 mol) 4-(hexylamino)pyridine in 50 ml acetonitrile was added dropwise to a solution containing 10.7 g (0.03 mol) 1,14-dibromotetradecane in 250 ml of acetonitrile, and the resulting mixture was refluxed for 22 hours. The reaction mixture was then evaporated to dryness under reduced pressure.

De gjenværende faste stoffer ble oppløst i acetonitril, og The remaining solids were dissolved in acetonitrile, and

den resulterende oppløsning behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under redusert trykk, og den resulterende olje utkrystallisert fra acetonitril. Produktet ble oppsamlet ved filtrering og tørket i 48 timer ved 70°C/0,1 mm Hg, hvorved man fikk 13,4 g 1,14-bis-[4-(hexylamino)1-pyridinium]tetradecandibromid, smp. 91-93°C. the resulting solution treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under reduced pressure and the resulting oil crystallized from acetonitrile. The product was collected by filtration and dried for 48 hours at 70°C/0.1 mm Hg, whereby 13.4 g of 1,14-bis-[4-(hexylamino)1-pyridinium]tetradecanedibromide, m.p. 91-93°C.

Eksempel 6 Example 6

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 2, men ved å anvende 5,0 g 1,14-bis-[4-(hexylamino)-1-pyridinium]-tetradecandibromid, fikk man fremstilt 4,33 g av det tilsvarende diklorid, smp. 94-95°C. By using the same procedure as described in Ex. 2, but by using 5.0 g of 1,14-bis-[4-(hexylamino)-1-pyridinium]-tetradecanedibromide, 4.33 g of the corresponding dichloride was produced, m.p. 94-95°C.

Eksempel 7 Example 7

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 5C, men ved å benytte 10,7 g (0,06 mol) 4-(hexylamino)pyridin og 9,85 g (0,03 mol) 1,12-dibromdodecan, fikk man fremstilt 17,6 g 1,12-bis-[4-(hexylamino)-1-pyridinium]dodecandibromid, smp. 122-124°C. By using the same procedure as described in Ex. 5C, but by using 10.7 g (0.06 mol) 4-(hexylamino)pyridine and 9.85 g (0.03 mol) 1,12-dibromododecane, 17.6 g of 1,12- bis-[4-(hexylamino)-1-pyridinium]dodecanedibromide, m.p. 122-124°C.

Eksempel 8 Example 8

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 2, men ved å benytte 5,0 g 1,12-bis-[4-(hexylamino)-1-pyridinium]-dodecandibromid fikk man fremstilt 3,6 9 g av det tilsvarende diklorid, smp. 86-88°C. By using the same procedure as described in Ex. 2, but by using 5.0 g of 1,12-bis-[4-(hexylamino)-1-pyridinium]-dodecanedibromide, 3.69 g of the corresponding dichloride was produced, m.p. 86-88°C.

Eksempel 9 Example 9

A. En blanding inneholdende 183,3 g (0,8 mol) N-(4-pyridyl)pyridiniumkloridhydroklorid og 162 g (0,98 mol) n-oktylaminhydroklorid ble oppvarmet på et oljebad på 225-230°C (indre temperatur på 188°C), og den resulterende væske ble omrørt ved denne temperatur i 2,5 timer. Reaksjonsblandingen ble så avkjølt til 70°C, fortynnet med 1 liter is og vann, gjort alkalisk med 30% vandig natriumhydroksyd og ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat, behandlet med avfargende karbon og fordampet til tørrhet under vakuum. Den resulterende olje ble avkjølt til -78°C. De halvfaste stoffer som dannet seg ble behandlet med eter, og det faste stoff ble oppsamlet ved filtrering, vasket med kald eter og tørket. Filtratet ga et nytt utbytte på 10 g. De samlede utbytter ble kombinert, oppløst i kloroform og deretter behandlet med avfargende karbon og filtrert (gjentatt 3 ganger), hvoretter kloroformopp-løsningen ble fordampet til tørrhet under redusert trykk. A. A mixture containing 183.3 g (0.8 mol) of N-(4-pyridyl)pyridinium chloride hydrochloride and 162 g (0.98 mol) of n-octylamine hydrochloride was heated in an oil bath at 225-230°C (internal temperature of 188°C), and the resulting liquid was stirred at this temperature for 2.5 hours. The reaction mixture was then cooled to 70°C, diluted with 1 liter of ice and water, made alkaline with 30% aqueous sodium hydroxide and extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate, treated with decolorizing carbon and evaporated to dryness under vacuum. The resulting oil was cooled to -78°C. The semi-solids that formed were treated with ether, and the solid was collected by filtration, washed with cold ether and dried. The filtrate gave another yield of 10 g. The combined yields were combined, dissolved in chloroform and then treated with decolorizing carbon and filtered (repeated 3 times), after which the chloroform solution was evaporated to dryness under reduced pressure.

Det resulterende faste stoff ble behandlet med eter, avkjølt, oppsamlet ved filtrering og vasket med kald eter-hexan, hvorved man fikk 63,3 g neste farveløst 4-(oktylamino)-pyridin, smp. 62-63°C. The resulting solid was treated with ether, cooled, collected by filtration and washed with cold ether-hexane to give 63.3 g of next colorless 4-(octylamino)-pyridine, m.p. 62-63°C.

B. Alternativt kan 4-(oktylamino)pyridin fremstilles på følgende måte: En blanding inneholdende 94 g (1 mol) 4-amino-pyridin, 384 g (3 mol) oktaldehyd, 7 g 10% palladium-på-karbon-hydrogeneringskatalysator og tilstrekkelig absolutt etanol til å gi et totalt volum på 1,2 liter, ble hydrogenert i 4,5 timer ved 70-90 oC under et indre hydrogentrykk pa ca. 3,3 kg/cm o. Etter avkjøling ble katalysatoren fjernet ved filtrering, og filtratet ble fordampet til tørrhet under redusert trykk. Den gjenværende olje ble utkrystallisert ved henstand, og det faste produkt ble behandlet med hexan, oppsamlet ved filtrering, vasket med fersk hexan og tørket ved 4 0°C under vakuum, hvorved man fikk 182 g 4-(oktylamino)-pyridin, smp. 70-73°C. C. En omrørt varm oppløsning inneholdende 10,0 g (0,04 9 mol) 4-(oktylamino)pyridin i 150 ml acetonitril ble dråpevis satt til en oppløsning inneholdende 7,4 g (0,0245 mol) 1,10-dibromdecan i 50 ml acetonitril, og den resulterende blanding ble kokt under tilbakeløp i 18 timer. Etter avkjø-ling og omrøring i 1 time ved romtemperatur ble det utfelte faste stoff samlet ved filtrering, vasket med acetonitril og tørket i 48 timer ved 85°C, og man fikk 15,6 g 1,10-bis-[4-(oktylamino)-1-pyridinium]decandibromid, smp. 163-164°C. B. Alternatively, 4-(octylamino)pyridine can be prepared as follows: A mixture containing 94 g (1 mol) of 4-amino-pyridine, 384 g (3 mol) of octaaldehyde, 7 g of 10% palladium-on-carbon hydrogenation catalyst and sufficient absolute ethanol to give a total volume of 1.2 litres, was hydrogenated for 4.5 hours at 70-90 oC under an internal hydrogen pressure of approx. 3.3 kg/cm o. After cooling, the catalyst was removed by filtration, and the filtrate was evaporated to dryness under reduced pressure. The remaining oil was crystallized on standing, and the solid product was treated with hexane, collected by filtration, washed with fresh hexane and dried at 40°C under vacuum to give 182 g of 4-(octylamino)pyridine, m.p. 70-73°C. C. A stirred hot solution containing 10.0 g (0.049 mol) 4-(octylamino)pyridine in 150 mL acetonitrile was added dropwise to a solution containing 7.4 g (0.0245 mol) 1,10-dibromodecane in 50 ml of acetonitrile, and the resulting mixture was refluxed for 18 hours. After cooling and stirring for 1 hour at room temperature, the precipitated solid was collected by filtration, washed with acetonitrile and dried for 48 hours at 85°C, and 15.6 g of 1,10-bis-[4-( octylamino)-1-pyridinium]decanedibromide, m.p. 163-164°C.

Eksempel 10 Example 10

A. Ved å bruke samme fremgangsmåte som beskrevet i eksempel 2, men ved å benytte 5,0 g 1,10-bis-[4-(oktylamino)-1-pyridinium]decandibromid fikk man fremstilt 4,31 g av det tilsvarende diklorid, smp. 213-214°C. A. By using the same procedure as described in example 2, but by using 5.0 g of 1,10-bis-[4-(octylamino)-1-pyridinium]decane dibromide, 4.31 g of the corresponding dichloride was produced , m.p. 213-214°C.

B. Alternativt kan en blanding inneholdende 61,8 g 4-(oktylamino)pyridin og 31,5 g 1,10-diklordecan omrøres og oppvarmes langsomt ved 12 0°C. Varmekilden ble fjernet, og temperaturen på den nå eksoterme reaksjon fortsatte å stige til 180°C. B. Alternatively, a mixture containing 61.8 g of 4-(octylamino)pyridine and 31.5 g of 1,10-dichlorodecane can be stirred and heated slowly at 120°C. The heat source was removed and the temperature of the now exothermic reaction continued to rise to 180°C.

Så snart reaksjonsblandingen begynte å utkrystallisere seg, ble 250 ml N,N-dimetylformamid raskt tilsatt, og den resulterende blanding ble oppvarmet, hvorved man fikk en klar homogen oppløsning som ble avkjølt til 0°C. Det utfelte produkt ble oppsamlet ved filtrering, vasket med eter og tørket i 24 timer under vakuum ved 60°C, hvorved man fikk 73 g 1,10-bis [4- (oktylamino) -1-pyridinium] decandiklorid, smp. 215-217°C. As soon as the reaction mixture began to crystallize, 250 ml of N,N-dimethylformamide was quickly added and the resulting mixture was heated to give a clear homogeneous solution which was cooled to 0°C. The precipitated product was collected by filtration, washed with ether and dried for 24 hours under vacuum at 60°C, whereby 73 g of 1,10-bis[4-(octylamino)-1-pyridinium] decane dichloride were obtained, m.p. 215-217°C.

Eksempel 11 Example 11

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 9C, By using the same procedure as described in Ex. 9C,

men ved å benytte 11,1 g (0,054 mol) 4-(oktylamino)pyridin og 7,34 g (0,027 mol) 1,8-dibromoktan og oppvarme blandingen i 6 timer under tilbakeløp, fikk man 15,6 g 1,8-bis-[4-(oktyl-amino) -1-pyridinium]oktandibromid, smp. 174-175°C. but by using 11.1 g (0.054 mol) of 4-(octylamino)pyridine and 7.34 g (0.027 mol) of 1,8-dibromooctane and heating the mixture for 6 hours under reflux, 15.6 g of 1,8 -bis-[4-(octyl-amino)-1-pyridinium]octane dibromide, m.p. 174-175°C.

Eksempel 12»Example 12»

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 2, men ved å benytte 5,0 g 1,8-bis-[4-(oktylamino)-1-pyridinium]oktan-dibromid, fikk man 4,30 g av det tilsvarende diklorid, smp. 210-211°C. By using the same procedure as described in Ex. 2, but by using 5.0 g of 1,8-bis-[4-(octylamino)-1-pyridinium]octane dibromide, 4.30 g of the corresponding dichloride was obtained, m.p. 210-211°C.

Eksempel 13 Example 13

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 9C, men ved å benytte 11,1 g (0,054 mol) 4(oktylamino)pyridin og 6,6 g (0,027 mol) 1,6-dibromhexan og oppvarme og koke blandingen under tilbakeløp i 9 timer, fikk man fremstilt 15,1 g 1,6-bis-[4-(oktylamino)-1-pyridinium]hexandibromid, smp. 136-138°C. By using the same procedure as described in Ex. 9C, but by using 11.1 g (0.054 mol) 4(octylamino)pyridine and 6.6 g (0.027 mol) 1,6-dibromohexane and heating and refluxing the mixture for 9 hours, 15.1 g 1,6-bis-[4-(octylamino)-1-pyridinium]hexanedibromide, m.p. 136-138°C.

Eksempel 14 Example 14

Man brukte samme fremgangsmåte som beskrevet i Eks. 2, men anvendte 5,0 g 1,6-bis-[4-(oktylamino)-1-pyridinium]hexandi-bromid <p>g fikk fremstilt 4,23 g av det tilsvarende diklorid, smp. 189-191°C. The same procedure was used as described in Ex. 2, but used 5.0 g of 1,6-bis-[4-(octylamino)-1-pyridinium]hexane di-bromide <p>g produced 4.23 g of the corresponding dichloride, m.p. 189-191°C.

Eksempel 15 Example 15

En omrørt varm oppløsning inneholdende 2,06 g (0,01 mol) 4-(oktylamino)pyridin i 15 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 1,37 g (0,005 mol) 1,6-hexan-dioldimetansulfonat i 10 ml acetonitril, og den resulterende blanding ble kokt under tilbakeløp i 20 timer. Reaksjonsblandingen ble fordampet til tørrhet under redusert trykk, A stirred hot solution containing 2.06 g (0.01 mol) 4-(octylamino)pyridine in 15 ml acetonitrile was added dropwise to a solution containing 1.37 g (0.005 mol) 1,6-hexane-diol dimethanesulfonate in 10 ml acetonitrile , and the resulting mixture was refluxed for 20 hours. The reaction mixture was evaporated to dryness under reduced pressure,

og det gjenværende gummiaktige materiale ble behandlet med eter, hvorved man fikk et farveløst hygroskopisk fast stoff. Dette produkt ble gjenoppløst i en blanding av etanol, benzen og acetonitril, og den resulterende oppløsning fordampet til tørrhet under redusert trykk. Resten ble behandlet med eter, og det resulterende hvite, faste stoff ble raskt samlet ved filtrering, vasket med vannfri eter og tørket i 72 timer ved and the remaining gummy material was treated with ether to give a colorless hygroscopic solid. This product was redissolved in a mixture of ethanol, benzene and acetonitrile and the resulting solution evaporated to dryness under reduced pressure. The residue was treated with ether, and the resulting white solid was quickly collected by filtration, washed with anhydrous ether, and dried for 72 hours at

28°C/0,1 mm Hg, hvorved man fikk 2,65 g 1,6-bis-[4-(oktyl-amino) -1-pyridinium]hexandimetansulfonat som et voksaktig hvitt fast stoff. 28°C/0.1 mm Hg, yielding 2.65 g of 1,6-bis-[4-(octyl-amino)-1-pyridinium]hexane dimethanesulfonate as a waxy white solid.

Molvekt-beregning: Molecular weight calculation:

Eksempel 16 Example 16

Man brukte samme fremgangsmåte som beskrevet i Eks. 9C, men anvendte 14,24 g (0,08 mol) 4-(hexylamino)-pyridin og 8,64 g (0,04 mol) 1,4-dibrombutan, og etter behandling av råproduktet med en blanding av acetonitril og aceton, fikk man 20,45 g 1,4-bis-[4-(hexylamino)-1-pyridinium]butandibromid, smp. 199-201°C. The same procedure was used as described in Ex. 9C, but using 14.24 g (0.08 mol) 4-(hexylamino)-pyridine and 8.64 g (0.04 mol) 1,4-dibromobutane, and after treatment of the crude product with a mixture of acetonitrile and acetone , 20.45 g of 1,4-bis-[4-(hexylamino)-1-pyridinium]butane dibromide were obtained, m.p. 199-201°C.

Eksempel 17 Example 17

Man brukte samme fremgangsmåte som beskrevet i Eks. 9C, men anvendte 10,7 g (0,06 mol) 4-(hexylamino)-pyridin og 7,32 g (0,03 mol) 1,6-dibromhexan, og etter behandling av råproduktet med en blanding av eter, acetonitril,og aceton fikk man ialt 14,90 g 1,6-bis-[4-(hexylamino)-1-pyridinium]hexandi-bromid, smp. 178-179°C. The same procedure was used as described in Ex. 9C, but using 10.7 g (0.06 mol) 4-(hexylamino)-pyridine and 7.32 g (0.03 mol) 1,6-dibromohexane, and after treatment of the crude product with a mixture of ether, acetonitrile , and acetone gave a total of 14.90 g of 1,6-bis-[4-(hexylamino)-1-pyridinium]hexanedibromide, m.p. 178-179°C.

Eksempel 18 Example 18

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 9C, By using the same procedure as described in Ex. 9C,

men ved å anvende 10,7 g (0,06 mol) 4-(hexylamino)-pyridin og 7,75 g (0,03 mol) 1,7-dibromheptan, fikk man etter å ha behandlet råproduktet med en blanding av acetonitril og aceton, ialt 16,4 g 1,7-bis-[4-(hexylamino)-1-pyridinium]-heptandibromid, smp. 157-158°C. but by using 10.7 g (0.06 mol) of 4-(hexylamino)-pyridine and 7.75 g (0.03 mol) of 1,7-dibromoheptane, after treating the crude product with a mixture of acetonitrile and acetone, a total of 16.4 g of 1,7-bis-[4-(hexylamino)-1-pyridinium]-heptanedibromide, m.p. 157-158°C.

Eksempel 19 Example 19

Man brukte samme fremgangsmåte som beskrevet i Eks. 9C, men anvendte 10,7 g (0,06 mol) 4-(hexylamino)-pyridin og 8,6 g (0,03 mol) 1,9-dibromnonan, og fikk ialt 17,15 g l,9-bis-[4-(hexylamino)-1-pyridinium]-nonandibromid, smp. 114-115°C. The same procedure was used as described in Ex. 9C, but used 10.7 g (0.06 mol) 4-(hexylamino)-pyridine and 8.6 g (0.03 mol) 1,9-dibromononane, and obtained a total of 17.15 g 1,9-bis- [4-(hexylamino)-1-pyridinium]-nonane dibromide, m.p. 114-115°C.

Eksempel 2 0 Example 2 0

Man brukte samme fremgangsmåte som beskrevet i Eks. 9C, men anvendte 15,4 g (0,08 mol) 4-(heptylamino)pyridin og 8,64 g (0,04 mol) 1,4-dibrombutan, og fikk 23,1 g 1,4-bis-[4-(hep-tylamino) -1-pyridinium] butandibromid, smp. 229-230°C. The same procedure was used as described in Ex. 9C, but used 15.4 g (0.08 mol) 4-(heptylamino)pyridine and 8.64 g (0.04 mol) 1,4-dibromobutane, and obtained 23.1 g 1,4-bis-[ 4-(heptylamino)-1-pyridinium]butane dibromide, m.p. 229-230°C.

Eksempel 21 Example 21

Man brukte samme fremgangsmåte som beskrevet i Eks. 9C, The same procedure was used as described in Ex. 9C,

men anvendte 10,0 g (0,052 mol) 4-(heptylamino)pyridin og 6,7 g (0,026 mol) 1,7-dibromheptan og fikk ialt fremstilt 14,05 g 1, 7—bis—[4—(heptylamino)—1—pyridinium]heptandibromid, smp. 14 2-143°C. but used 10.0 g (0.052 mol) 4-(heptylamino)pyridine and 6.7 g (0.026 mol) 1,7-dibromoheptane and obtained a total of 14.05 g of 1,7-bis-[4-(heptylamino) —1—pyridinium]heptanedibromide, m.p. 14 2-143°C.

Eksempel 22 Example 22

Ved å bruke samme fremgangsmåte som beskrevet i Eks. 9C, men ved å anvende 11,6 g (0,06 mol) 4-(heptylamino)pyridin og 8,2 g (0,03 mol) 1,8-dibromoktan, fikk man etter omkrystallisering fra acetonitril og eter ialt 18,6 g 1,8-bis-[4-(heptyl-amino )-1-pyridinium]oktandibromid, smp. 161-162°C. By using the same procedure as described in Ex. 9C, but by using 11.6 g (0.06 mol) 4-(heptylamino)pyridine and 8.2 g (0.03 mol) 1,8-dibromooctane, a total of 18 was obtained after recrystallization from acetonitrile and ether, 6 g of 1,8-bis-[4-(heptyl-amino)-1-pyridinium]octane dibromide, m.p. 161-162°C.

Eksempel 23 Example 23

Man brukte samme fremgangsmåte som angitt i Eks. 2, men benyttet 5,0 g (0,0076 mol) 1,8-bis-[4-(heptylamino)-1-pyri-dinium] oktandibromid og fikk fremstilt 4,1 g av den tilsvarende diklorid, smp. 206-208°C. The same procedure was used as indicated in Ex. 2, but used 5.0 g (0.0076 mol) of 1,8-bis-[4-(heptylamino)-1-pyridinium] octandibromide and obtained 4.1 g of the corresponding dichloride, m.p. 206-208°C.

Eksempel 24 Example 24

Man brukte samme fremgangsmåte som angitt i Eks. 9C, men benyttet 15,4 g (0,08 mol) 4-(heptylamino)pyridin og 11,44 g 1.9- dibromnonan, og fikk fremstilt 21,3 g 1,9-bis-[4-(heptyl-amino) -1-pyridinium]nonandibromid, smp. 115-116°C. The same procedure was used as indicated in Ex. 9C, but used 15.4 g (0.08 mol) 4-(heptylamino)pyridine and 11.44 g 1,9-dibromononane, and obtained 21.3 g of 1,9-bis-[4-(heptyl-amino) -1-pyridinium]nonane dibromide, m.p. 115-116°C.

Eksempel 25 Example 25

Man brukte samme fremgangsmåte som beskrevet i Eks. 2, men benyttet 5,0 g.(0,0075 mol) 1,9-bis-[4-(heptylamino)-1-pyridinium]nonandibromid, og fikk fremstilt 4,2 g av det tilsvarende diklorid, smp. 154-155°C. The same procedure was used as described in Ex. 2, but used 5.0 g. (0.0075 mol) 1,9-bis-[4-(heptylamino)-1-pyridinium]nonane dibromide, and obtained 4.2 g of the corresponding dichloride, m.p. 154-155°C.

Eksempel 26 Example 26

Man brukte samme fremgangsmåte som angitt i Eks. 9C, men benyttet 15,4 g (0,08 mol) 4-(heptylamino)pyridin og 12,0 g (0,04 mol) 1,10-dibromdecan, og fikk fremstilt 25,7 g 1.10- bis-[4-(heptylamino)-1-pyridinium]decandibromid, smp. 163-165°C. The same procedure was used as indicated in Ex. 9C, but used 15.4 g (0.08 mol) 4-(heptylamino)pyridine and 12.0 g (0.04 mol) 1,10-dibromodecane, and obtained 25.7 g of 1,10-bis-[4 -(heptylamino)-1-pyridinium]decanedibromide, m.p. 163-165°C.

Eksempel 27 Example 27

Man brukte samme fremgangsmåte som beskrevet i Eks. 2, men benyttet 5,0 g (0,0073 mol) 1,10-bis-[4-(heptylamino)-1-pyridinium]decandibromid, og fikk fremstilt 4,35 g av det tilsvarende diklorid, smp. 209-210°C. The same procedure was used as described in Ex. 2, but used 5.0 g (0.0073 mol) of 1,10-bis-[4-(heptylamino)-1-pyridinium]decanedibromide, and obtained 4.35 g of the corresponding dichloride, m.p. 209-210°C.

Eksempel 28 Example 28

En omrørt suspensjon av 3 0 ml av en syntetisk anionutbytningsharpiks i hydroksydformen "Amberlite IRA 4 00" i 150 ml vann ble dråpevis tilsatt 48% vandig fluss-syre inntil blandingen ble sur. Etter omrøring i ytterligere en halv time ble suspen-sjonen helt over i en kolonne. Kolonnen ble tappet, og harpiksen vasket med en oppløsning inneholdende 15 ml 48% vandig fluss-syre i 185 ml destillert vann. Harpiksen ble så vasket med destillert vann inntil eluatet var svakt surt, og så suksessivt med 20%, 40% og 50% vandig metanol og til slutt med absolutt metanol inntil eluatet var nøytralt. På toppen av denne kolonnen av ioneutbytningsharpiksen i fluoridformen tilsatte man nå en oppløsning inneholdende 0,25 g (0,000365 mol) av 1,10-bis-[4-(heptylamino)-1-pyridinium]decandibromid i 1 ml metanol. Man oppsamlet de ialt fremfraksjoner på 15 ml. De første tre fraksjoner ble slått sammen og fordampet til tørrhet under redusert trykk. Den oljeaktige rest ble opp-løst i en blanding av toluen og etanol, og den resulterende oppløsning fordampet under redusert trykk til tørrhet. Den gjenværende olje ble gjenoppløst i en blanding av benzen og aceton, og oppløsningen konsentrert til et lite volum. Det faste stoff som skilte seg ut ble oppsamlet ved filtrering og tørket i 24 timer ved 24°C/0,1 mm Hg, hvorved man fikk 0,11 g urent 1,10-bis-[4-(heptylamino)-1-pyridinium]decandi-fluorid, smp. 85-90°C. A stirred suspension of 30 ml of a synthetic anion exchange resin in the hydroxide form "Amberlite IRA 4 00" in 150 ml of water was added dropwise with 48% aqueous hydrofluoric acid until the mixture became acidic. After stirring for a further half an hour, the suspension was poured into a column. The column was drained and the resin washed with a solution containing 15 ml of 48% aqueous hydrofluoric acid in 185 ml of distilled water. The resin was then washed with distilled water until the eluate was slightly acidic, and then successively with 20%, 40% and 50% aqueous methanol and finally with absolute methanol until the eluate was neutral. On top of this column of the ion exchange resin in the fluoride form was now added a solution containing 0.25 g (0.000365 mol) of 1,10-bis-[4-(heptylamino)-1-pyridinium]decanedibromide in 1 ml of methanol. The total forward fractions of 15 ml were collected. The first three fractions were combined and evaporated to dryness under reduced pressure. The oily residue was dissolved in a mixture of toluene and ethanol, and the resulting solution evaporated under reduced pressure to dryness. The remaining oil was redissolved in a mixture of benzene and acetone, and the solution concentrated to a small volume. The solid that separated was collected by filtration and dried for 24 hours at 24°C/0.1 mm Hg to give 0.11 g of impure 1,10-bis-[4-(heptylamino)-1- pyridinium]decandi fluoride, m.p. 85-90°C.

Eksempel 29 Example 29

A. En fast blanding inneholdende 115 g (0,5 mol) N-(4-pyridyl)pyridiniumkloridhydroklorid og 119 g (0,66 mol) n-nonylaminhydroklorid ble oppvarmet på et oljebad til en temperatur på 220°C (indre temperatur 190-194°C), og den resulterende væske omrørt ved denne temperatur i 2 timer. Reaksjonsblandingen ble avkjølt til 80°C, fortynnet med A. A solid mixture containing 115 g (0.5 mol) of N-(4-pyridyl)pyridinium chloride hydrochloride and 119 g (0.66 mol) of n-nonylamine hydrochloride was heated in an oil bath to a temperature of 220°C (internal temperature 190 -194°C), and the resulting liquid stirred at this temperature for 2 hours. The reaction mixture was cooled to 80°C, diluted with

1,2 liter is og vann, gjort alkalisk med 35% vandig natriumhydroksyd og ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat, behandlet med avfargende karbon, filtrert og fordampet til tørrhet under redusert trykk. Den gjenværende viskøse olje ble avkjølt til 1.2 liters of ice and water, made alkaline with 35% aqueous sodium hydroxide and extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate, treated with decolorizing carbon, filtered and evaporated to dryness under reduced pressure. The remaining viscous oil was cooled to

-78°C og så behandlet med eter. Det resulterende faste stoff ble oppsamlet ved filtrering og vasket med kald eter. Filtratet ga et nytt utbytte av et fast stoff. De samlede faste stoffer ble gjenoppløst i kloroform, og den resulterende oppløsning ble behandlet med avfargende karbon og filtrert. Dette ble gjentatt en gang til, og filtratet ble så fordampet til tørrhet under redusert trykk. Det gjenværende halvfaste stoff ble behandlet med eter og avkjølt, og man fikk et nesten farveløst fast stoff som ble oppsamlet ved filtrering, vasket med kald eter og tørket. Dette faste stoff ble løst i kloroform, og den resulterende oppløsning ble behandlet med av- -78°C and then treated with ether. The resulting solid was collected by filtration and washed with cold ether. The filtrate gave another yield of a solid. The combined solids were redissolved in chloroform, and the resulting solution was treated with decolorizing carbon and filtered. This was repeated once more and the filtrate was then evaporated to dryness under reduced pressure. The remaining semi-solid was treated with ether and cooled to give an almost colorless solid which was collected by filtration, washed with cold ether and dried. This solid was dissolved in chloroform, and the resulting solution was treated with de-

fargende karbon, filtrert og fordampet til tørrhet under redusert trykk. Man avkjølte det halvfaste stoff og behandlet dette med eter, noe som ga et farveløst fast stoff som ble oppsamlet ved filtrering, vasket med kald eter og tørket, hvoretter man fikk 51,7 g 4-(nonylamino)pyridin, smp. 59-60°C. Filtratet ga et nytt utbytte på 11,6 g, smp. 55-57°C. coloring carbon, filtered and evaporated to dryness under reduced pressure. The semi-solid was cooled and treated with ether to give a colorless solid which was collected by filtration, washed with cold ether and dried to give 51.7 g of 4-(nonylamino)pyridine, m.p. 59-60°C. The filtrate gave a new yield of 11.6 g, m.p. 55-57°C.

B. Alternativt kan 4-(nonylamino)pyridin fremstilles på følgende måte: En blanding inneholdende 39,5 g (0,42 mol) 4- aminopyridin, 175 g (1,24 mol) nonylaldehyd, 5,0 g 10% palladium-på-karbon~hydrogeneringskatalysator og tilstrekkelig absolutt etanol til at man fikk et totalt volum på 60 ml, ble oppvarmet og hydrogenert under et begynnende hydrogentrykk på 4,3 kg/cm inntil absorbsjonen av hydrogen stoppet opp. Reaksjonsblandingen ble filtrert for å fjerne katalysatoren, og filtratet fordampet til tørrhet under redusert trykk. Den gjenværende olje ble vakuumdestillert for å B. Alternatively, 4-(nonylamino)pyridine can be prepared as follows: A mixture containing 39.5 g (0.42 mol) 4-aminopyridine, 175 g (1.24 mol) nonylaldehyde, 5.0 g 10% palladium- on-carbon hydrogenation catalyst and sufficient absolute ethanol to give a total volume of 60 ml was heated and hydrogenated under an initial hydrogen pressure of 4.3 kg/cm until the absorption of hydrogen stopped. The reaction mixture was filtered to remove the catalyst and the filtrate evaporated to dryness under reduced pressure. The remaining oil was vacuum distilled to

fjerne eventuell nonylalkohol som måtte være fremstilt. Den fraksjon som kokte ved 63-64°C/4,5 mm ble oppsamlet og satt tilside. Resten ble behandlet med eter og avkjølt til -78°C. Det faste stoff som skilte seg ut ble oppsamlet ved filtrering og vasket med kald eter. Dette produkt ble oppløst i kloroform, den resultende oppløsning behandlet med avfargende karbon, filtrert, hvoretter filtratet ble fordampet til tørr-het. Resten ble behandlet med eter og avkjølt til -78°C. remove any nonyl alcohol that may have been produced. The fraction boiling at 63-64°C/4.5 mm was collected and set aside. The residue was treated with ether and cooled to -78°C. The solid that separated was collected by filtration and washed with cold ether. This product was dissolved in chloroform, the resulting solution treated with decolorizing carbon, filtered, after which the filtrate was evaporated to dryness. The residue was treated with ether and cooled to -78°C.

Det faste stoff ble oppsamlet ved filtrering, vasket med kald eter og lufttørket, hvoretter man fikk 27,0 g 4-(nonylamino)-pyridin, smp. 57-59°C. The solid was collected by filtration, washed with cold ether and air-dried, after which 27.0 g of 4-(nonylamino)-pyridine were obtained, m.p. 57-59°C.

C. En omrørt suspensjon av 11,0 g (0,05 mol) 4-(nonyl-amino) pyridin i 15 0 ml acetonitril ble oppvarmet inntil man fikk en klar homogen oppløsning. Denne klare oppløsning ble dråpevis tilsatt en oppløsning inneholdende 6,8 g (0,025 mol) 1,8-dibromoktan i 50 ml acetonitril, og den resulterende blanding ble kokt i 19 timer under tilbakeløp, og man fikk utfelt et fast stoff. Etter avkjøling ble stoffet frafiltrert, gjenoppløst i metanol og oppløsningen ble behandlet med avfargende karbon, filtrert og fordampet til tørrhet under redusert trykk. Behandling av den gjenværende olje med eter inneholdende mindre mengde acetonitritt, ga et farveløst krystal-linsk stoff som ble oppsamlet ved filtrering og tørket, og man fikk 15,5 g 1,8-bis-[4-(nonylamino)-1-pyridinium]oktan-dibromid, smp. 178-179°G. C. A stirred suspension of 11.0 g (0.05 mol) 4-(nonyl-amino)pyridine in 150 ml acetonitrile was heated until a clear homogeneous solution was obtained. To this clear solution was added dropwise a solution containing 6.8 g (0.025 mol) of 1,8-dibromooctane in 50 ml of acetonitrile, and the resulting mixture was refluxed for 19 hours, and a solid was precipitated. After cooling, the substance was filtered off, redissolved in methanol and the solution was treated with decolorizing carbon, filtered and evaporated to dryness under reduced pressure. Treatment of the remaining oil with ether containing a small amount of acetonitrite gave a colorless crystalline substance which was collected by filtration and dried to give 15.5 g of 1,8-bis-[4-(nonylamino)-1-pyridinium ]octane dibromide, m.p. 178-179°C.

Eksempel 30 Example 30

Man brukte samme fremgangsmåte som i Eks. 29C, men anvendte 3,54 g (0,026 mol) 4-(propylamino)pyridin og 3,90 g (0,013 mol) 1,10-dibromdecan, og fikk fremstilt 5,19 g 1,10-bis-[4-(propyl-amino) -1-pyridinium] decandibromid, smp. 206-207°C. The same procedure was used as in Ex. 29C, but used 3.54 g (0.026 mol) of 4-(propylamino)pyridine and 3.90 g (0.013 mol) of 1,10-dibromodecane, and obtained 5.19 g of 1,10-bis-[4-( propyl-amino)-1-pyridinium] decanedibromide, m.p. 206-207°C.

Eksempel 31 Example 31

Man brukte samme fremgangsmåte som i Eks. 29C, men anvendte 14,24 g (0,08 mol) 4-(hexylamino)pyridin og 9,20 g (0,04 mol) 1,5-dibrompentan og fikk etter omkrystallisering fra acetonitril og aceton ialt 12,3 g 1,5-bis-[4-(hexylamino)-1-pyri-dinium] pentandibromid, smp. 155-156°C. The same procedure was used as in Ex. 29C, but used 14.24 g (0.08 mol) 4-(hexylamino)pyridine and 9.20 g (0.04 mol) 1,5-dibromopentane and obtained after recrystallization from acetonitrile and acetone a total of 12.3 g 1 ,5-bis-[4-(hexylamino)-1-pyridinium]pentane dibromide, m.p. 155-156°C.

Eksempel 32 Example 32

Man brukte fremgangsmåten fra Eks. 29C, men anvendte 10,7 g (0,06 mol) 4-(hexylamino)pyridin og 8,2 g (0,03 mol) 1,8-dibromoktan og fikk ialt 16,3 g 1,8-bits-[4-(hexylamino)-1-pyri-dinium] oktandibromid, smp. 180-181°C. The procedure from Ex. 29C, but used 10.7 g (0.06 mol) 4-(hexylamino)pyridine and 8.2 g (0.03 mol) 1,8-dibromooctane and obtained a total of 16.3 g 1,8-bit-[ 4-(hexylamino)-1-pyridinium] octandibromide, m.p. 180-181°C.

Eksempel 33 Example 33

Man brukte samme fremgangsmåte som i Eks. 29C, men anvendte 12,5 g (0,07 mol) 4-(hexylamino)pyridin og 10,5 g (0,035 mol) 1,10-dibromdecan og fikk fremstilt 16,0 g 1,10-bis-[4-(hexyl-amino) -1-pyridinium]decandibromid, smp. 148-149°C. The same procedure was used as in Ex. 29C, but used 12.5 g (0.07 mol) 4-(hexylamino)pyridine and 10.5 g (0.035 mol) 1,10-dibromodecane and obtained 16.0 g 1,10-bis-[4- (hexyl-amino)-1-pyridinium]decanedibromide, m.p. 148-149°C.

Eksempel 34 Example 34

Fremgangsmåten var som beskrevet i Eks. 29C, men man anvendte 13,4 g (0,076 mol) 4-(cyklohexylamino)pyridin og 10,34 g (0,038 mol) 1,8-dibromoktan, og fikk fremstilt 19,1 g 1,8-bis-[4-(cyklohexylamino)-1-pyridinium]oktandibromid, smp. 270-271°C. The procedure was as described in Ex. 29C, but 13.4 g (0.076 mol) of 4-(cyclohexylamino)pyridine and 10.34 g (0.038 mol) of 1,8-dibromooctane were used, and 19.1 g of 1,8-bis-[4- (cyclohexylamino)-1-pyridinium]octane dibromide, m.p. 270-271°C.

Eksempel 35 Example 35

Man brukte fremgangsmåten som angitt i Eks. 29C, men brukte 13,4 g (0,076 mol) 4-(cyklohexylamino)pyridin og 10,8 g (0,038 mol) 1,9-dibromnonan- og fikk fremstilt 16,3 g 1,9-bis-[4-(cyklohexylamino)-1-pyridinium]nonandibromid, smp. 149-151°C. The procedure as stated in Ex. 29C, but used 13.4 g (0.076 mol) 4-(cyclohexylamino)pyridine and 10.8 g (0.038 mol) 1,9-dibromononane- and obtained 16.3 g 1,9-bis-[4-( cyclohexylamino)-1-pyridinium]nonanedibromide, m.p. 149-151°C.

Eksempel 36 Example 36

Fremgangsmåten var som angitt i Eks. 29C, men man brukte 13,4 g (0,076 mol) 4-(cyklohexylamino)pyridin og 11,4 g (0,038 mol) . 1,10-dibromdecan og fikk fremstilt 19,0 g 1,10-bis-[4-(cyklo-hexylamino)-1-pyridinium] decandibromid, smp. 226-227°C. The procedure was as stated in Ex. 29C, but 13.4 g (0.076 mol) of 4-(cyclohexylamino)pyridine and 11.4 g (0.038 mol) were used. 1,10-dibromodecane and obtained 19.0 g of 1,10-bis-[4-(cyclohexylamino)-1-pyridinium] decanedibromide, m.p. 226-227°C.

Eksempel 37 Example 37

A. En blanding inneholdende 298,0 g (1,33 mol) N-(4-pyridyl)pyridiniumkloridhydroklorid og 322 g (2 mol) 2-etylhexylaminhydroklorid ble i 2 timer under omrøring oppvarmet på et oljebad ved en .temperatur på 215°C. Blandingen ble avkjølt til 60°C, fortynnet med 500 ml vann og holdt kald ved tilsetning av is, samtidig som den ble gjort alkalisk med 35% vandig natriumhydroksyd. Den alkaliske blanding ble ekstrahert med eter, og eterekstraktet ble tørket over vannfritt natriumsulfat og fordampet til tørrhet. Den gjenværende olje ble destillert under redusert trykk,og man fikk 101,0 g 4-(2-etylhexylamino)pyridin, kp. 145-150°C/0,9 mm. A. A mixture containing 298.0 g (1.33 mol) N-(4-pyridyl)pyridinium chloride hydrochloride and 322 g (2 mol) 2-ethylhexylamine hydrochloride was heated for 2 hours with stirring in an oil bath at a temperature of 215° C. The mixture was cooled to 60°C, diluted with 500 ml of water and kept cold by the addition of ice, while being made alkaline with 35% aqueous sodium hydroxide. The alkaline mixture was extracted with ether, and the ether extract was dried over anhydrous sodium sulfate and evaporated to dryness. The remaining oil was distilled under reduced pressure, and 101.0 g of 4-(2-ethylhexylamino)pyridine was obtained, b.p. 145-150°C/0.9 mm.

B. Alternativt kan 4-(2-etylhexylamino)pyridin fremstilles på følgende måte: En omrørt oppløsning inneholdende 800 g (8,4 mol) 4-amino-pyridin og 15 00 ml trietylamin i 6,4 1 diklormetan ble over 3 timer tilsatt en oppløsning inneholdende 1610 g (10,0 mol) 2-etylhexanoylklorid i 1,6 1 diklormetan. Under tilsetningen ble temperaturen holdt på 15°C. Etter at tilsetningen var ferdig, ble blandingen oppvarmet på et dampbad i 2 timer. Etter avkjøling ble reaksjonsblandingen vasket med vann, tørket over vannfritt natriumsulfat og behandlet med avfargende karbon og filtrert. Fordampning av filtratet ga 1843 g N-(4-pyridyl)-etylhexanamid. B. Alternatively, 4-(2-ethylhexylamino)pyridine can be prepared as follows: A stirred solution containing 800 g (8.4 mol) 4-amino-pyridine and 1500 ml triethylamine in 6.4 1 dichloromethane was added over 3 hours a solution containing 1610 g (10.0 mol) of 2-ethylhexanoyl chloride in 1.6 L of dichloromethane. During the addition, the temperature was kept at 15°C. After the addition was complete, the mixture was heated on a steam bath for 2 hours. After cooling, the reaction mixture was washed with water, dried over anhydrous sodium sulfate and treated with decolorizing carbon and filtered. Evaporation of the filtrate gave 1843 g of N-(4-pyridyl)-ethylhexanamide.

En blanding inneholdende 100 g (2,63 mol) litiumaluminiumhydrid i 2 1 tetrahydrofuran ble tilsatt med tilstrekkelig hastighet til å opprettholde forsiktig koking under tilbake-løp en oppløsning inneholdende 570 g (2,62 mol) N-(4-pyridyl)-2-etylhexanamid i 4 1 tetrahydrofuran. Etter at tilsetningen var ferdi, noe som tok ca. 3 timer, ble reaksjonsblandingen kokt under tilbakeløp i 7 timer. Etter avkjøling ble blandingen suksessivt behandlet med 100 ml vann, 100 ml 15% vandig natriumhydroksyd og 300 ml vann. De faste stoffer ble fjernet ved filtrering, og oppløsningsmidlet fordampet fra filtratet under redusert trykk. Den gjenværende olje ble kombinert med produktet fra et tilsvarende forsøk, og deretter vakuumdestillert, og man fikk 837 g 4-(2-etylehxylamino)pyridin, kp. 135-160°C/0,2 mm. A mixture containing 100 g (2.63 mol) of lithium aluminum hydride in 2 L of tetrahydrofuran was added at a rate sufficient to maintain gentle refluxing a solution containing 570 g (2.62 mol) of N-(4-pyridyl)-2 -ethylhexanamide in 4 1 tetrahydrofuran. After the addition was finished, which took approx. 3 hours, the reaction mixture was refluxed for 7 hours. After cooling, the mixture was successively treated with 100 ml of water, 100 ml of 15% aqueous sodium hydroxide and 300 ml of water. The solids were removed by filtration, and the solvent was evaporated from the filtrate under reduced pressure. The remaining oil was combined with the product from a similar experiment, and then vacuum distilled, and 837 g of 4-(2-ethylhexylamino)pyridine were obtained, b.p. 135-160°C/0.2 mm.

C. En omrørt varm oppløsning inneholdende 10,3 g (0,05 mol) 4-(2-etylhexylamino)pyridin i 50 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 8,2 g (0,025 mol) 1,12-dibromdecan i 170 ml acetonitril, og den resulterende blanding ble oppvarmet i 20 timer under tilbakeløp. Ved av-kjøling til 0°C fikk man et første utbytte av produktet og dette ble oppsamlet ved filtrering. Fordampning av filtratet og behandling av resten med eter ga et nytt utbytte. De samlede utbytter ble oppløst i metanol, den resulterende oppløs-ning behandlet med avragende karbon, filtrert, hvoretter fil-■tratet ble fordampet til tørrhet under redusert trykk. Den C. A stirred hot solution containing 10.3 g (0.05 mol) 4-(2-ethylhexylamino)pyridine in 50 ml acetonitrile was added dropwise to a solution containing 8.2 g (0.025 mol) 1,12-dibromodecane in 170 ml of acetonitrile, and the resulting mixture was heated for 20 hours under reflux. On cooling to 0°C, a first yield of the product was obtained and this was collected by filtration. Evaporation of the filtrate and treatment of the residue with ether gave a new yield. The combined yields were dissolved in methanol, the resulting solution treated with carbon, filtered, after which the filtrate was evaporated to dryness under reduced pressure. It

gjenværende olje ble avkjølt og behandlet med eter, og man fikk et noe farvet fast stoff. Omkrystallisering fra acetonitril og eter fulgt av en behandling av produktet med eter the remaining oil was cooled and treated with ether to give a slightly colored solid. Recrystallization from acetonitrile and ether followed by treatment of the product with ether

fulgt av acetonitril ga etter tørking i 72 timer under vakuum ved 60°C, ialt 14,7 g 1,12-bis-[4-(2-etyl-hexylamino)-1-pyri-dinium] dodecandibromid som farveløse granulater, smp. 146-147°C. followed by acetonitrile gave, after drying for 72 hours under vacuum at 60°C, a total of 14.7 g of 1,12-bis-[4-(2-ethyl-hexylamino)-1-pyridinium] dodecane dibromide as colorless granules, m.p. . 146-147°C.

Eksempel 38 Example 38

A. En blanding inneholdende 353,5 g (1,72 mol) 4-(2-etylhexylamino)pyridin og 205 g (0,86 mol) 1,12-diklordodecan ble oppvarmet ved 120°C. Varmekilden ble fjernet, temperaturen på den nå eksoterme reaksjon fortsatte å stige til 180-190°C. Da temperaturen var falt til 135°C,ble 1 liter acetonitril forsiktig tilsatt, og blandingen ble kokt under tilbakeløp inntil man fikk en klar oppløsning. Den varme acetonitriloppløsning ble kombinert med tilsvarende oppløsninger fra to tidligere for-søk, behandlet med avfargende karbon og filtrert. Filtratet ble avkjølt, og det utfelte produkt ble oppsamlet ved filtrering og vasket med kald acetonitril. To omkrystalliseringer fra acetonitril ga 970 g 1,12-bis-[4-(2-etylhexylamino)-1-pyridinium]dodecandiklorid, smp. 168-171°C. A. A mixture containing 353.5 g (1.72 mol) of 4-(2-ethylhexylamino)pyridine and 205 g (0.86 mol) of 1,12-dichlorododecane was heated at 120°C. The heat source was removed, the temperature of the now exothermic reaction continued to rise to 180-190°C. When the temperature had fallen to 135°C, 1 liter of acetonitrile was carefully added, and the mixture was refluxed until a clear solution was obtained. The warm acetonitrile solution was combined with corresponding solutions from two previous experiments, treated with decolorizing carbon and filtered. The filtrate was cooled, and the precipitated product was collected by filtration and washed with cold acetonitrile. Two recrystallizations from acetonitrile gave 970 g of 1,12-bis-[4-(2-ethylhexylamino)-1-pyridinium]dodecanedichloride, m.p. 168-171°C.

B. Alternativt kan man bruke samme fremgangsmåte som beskrevet i Eks. 2, men man må anvende 3,0 g (0,004 05 mol) 1,12-bis-[4 -(2-etylhexylamino)-1-pyridinium]-dodecandibromid B. Alternatively, you can use the same procedure as described in Ex. 2, but one must use 3.0 g (0.004 05 mol) of 1,12-bis-[4-(2-ethylhexylamino)-1-pyridinium]-dodecanedibromide

og fikk da fremstilt 2,0 g av det tilsvarende diklorid, smp. 172-173°C. and then produced 2.0 g of the corresponding dichloride, m.p. 172-173°C.

Eksempel 39 Example 39

Fremgangsmåten var som angitt i Eks. 37C, men man brukte 10,3 g (0,05 mol) 4-(oktylamino)pyridin og 6,45 g (0,025 mol) 1,7-dibromheptan og fikk fremstilt 14,85 g 1,7-bis-[4-(oktylamino)-1-pyridinium]heptandibromid, smp. 12 9-131°C. The procedure was as indicated in Ex. 37C, but 10.3 g (0.05 mol) of 4-(octylamino)pyridine and 6.45 g (0.025 mol) of 1,7-dibromoheptane were used and 14.85 g of 1,7-bis-[4 -(octylamino)-1-pyridinium]heptanedibromide, m.p. 12 9-131°C.

Eksempel 4 0 Example 4 0

A. Man brukte fremgangsmåten fra Eks. 37C, men anvendte 11,1 g (0,054 mol) 4-(oktylamino)pyridin og 7,72 g (0,027 mol) 1,9-dibromnonan og fikk fremstilt 17,0 g 1,9-bis-[4-(oktylamino)- A. The procedure from Ex. 37C, but used 11.1 g (0.054 mol) 4-(octylamino)pyridine and 7.72 g (0.027 mol) 1,9-dibromononane and obtained 17.0 g 1,9-bis-[4-(octylamino) )-

1-pyridinium]nonandibromid, smp. 117-119°C. 1-pyridinium]nonanedibromide, m.p. 117-119°C.

B. Det tilsvarende diklorid kan fremstilles som angitt i Eks. 2, og det hadde et smp. på 161-162°C. B. The corresponding dichloride can be prepared as indicated in Ex. 2, and it had a m.p. at 161-162°C.

Eksempel 41 Example 41

Fremgangsmåten var som i Eks. 37C, men man anvendte 10,3 g (0,05 mol) 4-(oktylamino)pyridin og 8,2 g (0,025 mol) 1,12-dibromdodecan og fikk 15,2 g 1,12-bis-[4-(oktylamino)-1-pyri-dinium] dodecandibromid, smp. 119-120°C. The procedure was as in Ex. 37C, but 10.3 g (0.05 mol) of 4-(octylamino)pyridine and 8.2 g (0.025 mol) of 1,12-dibromododecane were used and 15.2 g of 1,12-bis-[4- (octylamino)-1-pyridinium] dodecane dibromide, m.p. 119-120°C.

Eksempel 42 Example 42

Fremgangsmåten var som i Eks. 37C, men man brukte 5,8 g (0,028 mol) 4-(oktylamino)pyridin og 5,0 g (0,014 mol) I, 14-dibromtetradecan og fikk fremstilt 9,3 g 1,14-bis-[4-(oktylamino)-1-pyridinium]tetradecandibromid, smp. 113-115°C. The procedure was as in Ex. 37C, but 5.8 g (0.028 mol) of 4-(octylamino)pyridine and 5.0 g (0.014 mol) of 1,14-dibromotetradecane were used and 9.3 g of 1,14-bis-[4-( octylamino)-1-pyridinium]tetradecanedibromide, m.p. 113-115°C.

Eksempel 43 Example 43

Fremgangsmåten var som angitt i Eks. 37C, men man brukte II, 0 g (0,05 mol) 4-(nonylamino)pyridin og 6>1 g (0,025 mol) 1.6- dibromhexan, og fikk fremstilt 15,2 g 1,6-bis-[4-(nonyl-amino) -1-pyridinium] hexandibromid, smp. 152-154°C. The procedure was as stated in Ex. 37C, but II was used, 0 g (0.05 mol) 4-(nonylamino)pyridine and 6>1 g (0.025 mol) 1,6-dibromohexane, and 15.2 g 1,6-bis-[4- (nonyl-amino)-1-pyridinium] hexanedibromide, m.p. 152-154°C.

Eksempel 44 Example 44

Fremgangsmåten var som i Eks. 4, men man brukte 6,5 g (0,0095 mol) 1,6-bis-[4-(nonylamino)-1-pyridinium]hexandi-bromid og fikk ialt 4,95 g av det tilsvarende diklorid, smp.l94-195°C. The procedure was as in Ex. 4, but 6.5 g (0.0095 mol) of 1,6-bis-[4-(nonylamino)-1-pyridinium]hexanedibromide were used and a total of 4.95 g of the corresponding dichloride was obtained, m.p. 194 -195°C.

Eksempel 45 Example 45

Fremgangsmåten var som angitt i Eks. 37C, men man brukte The procedure was as stated in Ex. 37C, but one used

8,8 g (0,04 mol) 4-(nonylamino)pyridin og 5,2 g (0,02 mol) 1.7- dibromheptan og fikk fremstilt 12,2 g 1,7-bis-[4-(nonyl- 8.8 g (0.04 mol) 4-(nonylamino)pyridine and 5.2 g (0.02 mol) 1,7-dibromoheptane and obtained 12.2 g 1,7-bis-[4-(nonyl-

amino)-1-pyridinium]heptandibromid, smp. 132-134°C. amino)-1-pyridinium]heptanedibromide, m.p. 132-134°C.

Eksempel 46 Example 46

Fremgangsmåten var fra Eks. 37C, men man brukte 11,0 g The procedure was from Ex. 37C, but 11.0 g was used

(0,05 mol) 4-(nonylamino)pyridin og 7,15 g (0,025 mol) 1.9- dibromnonan og fikk fremstilt 15,7 g 1,9-bis-[4-(nonyl-amino) -1-pyridinium] nonandibromid, smp. 121-122°C. (0.05 mol) 4-(nonylamino)pyridine and 7.15 g (0.025 mol) 1,9-dibromononane and obtained 15.7 g of 1,9-bis-[4-(nonyl-amino)-1-pyridinium] nonadibromide, m.p. 121-122°C.

Eksempel 47 Example 47

Fremgangsmåten var som angitt i Eks. 37C, men man anvendte 11,0 g (0,05 mol) 4-(nonylamino)pyridin og 7,5 g (0,025 mol) 1.10- dibromdecan og fikk fremstilt 15,63 g 1,10-bis-[4-(nonyl-amino) -1-pyridinium] decandibromid, smp. 172-173°C. The procedure was as indicated in Ex. 37C, but 11.0 g (0.05 mol) of 4-(nonylamino)pyridine and 7.5 g (0.025 mol) of 1,10-dibromodecane were used and 15.63 g of 1,10-bis-[4-( nonyl-amino)-1-pyridinium] decanedibromide, m.p. 172-173°C.

Eksempel 48 Example 48

Man brukte fremgangsmåten fra Eks. 37C, men anvendte 10,12 g (0,046 mol) 4-(nonylamino)pyridin og 7,54 g (0,023 mol) 1,12-dibromdodecan og fikk fremstilt 16,4 g 1,12-bis-[4-(nonylamino)-1-pyridinium]dodecandibromid, smp. 105-106°C. The procedure from Ex. 37C, but used 10.12 g (0.046 mol) 4-(nonylamino)pyridine and 7.54 g (0.023 mol) 1,12-dibromododecane and obtained 16.4 g 1,12-bis-[4-(nonylamino) )-1-pyridinium]dodecanedibromide, m.p. 105-106°C.

Eksempel 4 9 Example 4 9

En omrørt varm oppløsning inneholdende 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin i 100 ml acetonitril ble dråpevis satt til en oppløsning inneholdende 6,9 g (0,03 mol) 1,5-dibrompentan i 25 ml acetonitril, og den resulterende opp-løsning kokt i 20 timer under tilbakeløp. Reaksjonsblandingen ble avkjølt og fortynnet med eter inntil den ble svakt uklar. Ytterligere avkjøling og omrøring ga et fast bunnfall som ble frafiltrert og vasket med en kald blanding av acetonitril og eter. Det faste stoff ble oppløst i etanol, og den resulterende oppløsning behandlet med avfargende karbon og filtrert. Fordampning av filtratet ga en blekt gul viskøs olje som utkrystalliserte seg fra acetonitrileter. A stirred hot solution containing 12.4 g (0.06 mol) of 4-(2-ethylhexylamino)pyridine in 100 ml of acetonitrile was added dropwise to a solution containing 6.9 g (0.03 mol) of 1,5-dibromopentane in 25 ml of acetonitrile, and the resulting solution boiled for 20 hours under reflux. The reaction mixture was cooled and diluted with ether until slightly cloudy. Further cooling and stirring gave a solid precipitate which was filtered off and washed with a cold mixture of acetonitrile and ether. The solid was dissolved in ethanol, and the resulting solution treated with decolorizing carbon and filtered. Evaporation of the filtrate gave a pale yellow viscous oil which crystallized from acetonitrile.

Det resulterende faste stoff ble oppsamlet ved filtrering, vasket med kald acetonitril-eter og tørket i 24 timer under vakuum ved 90°C og man fikk 13,6 g 1,5-bis-[4-(2-etylhexyl-amino) -1-pyridinium]pentandibromid, smp. 150-151°C. The resulting solid was collected by filtration, washed with cold acetonitrile ether and dried for 24 hours under vacuum at 90°C to give 13.6 g of 1,5-bis-[4-(2-ethylhexyl-amino)- 1-pyridinium]pentanedibromide, m.p. 150-151°C.

Eksempel 50 Example 50

Man brukte fremgangsmåten fra Eks. 4 9, men anvendte 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin og 7,32 g (0,03 mol) 1.6- dibromhexan, og fikk ialt 16,1 g l,6-bis-[4-(2-etyl-hexylamino)-1-pyridinium]hexandibromid, smp. 208-209°C. The procedure from Ex. 4 9, but used 12.4 g (0.06 mol) 4-(2-ethylhexylamino)pyridine and 7.32 g (0.03 mol) 1,6-dibromohexane, and obtained a total of 16.1 g 1,6-bis- [4-(2-ethylhexylamino)-1-pyridinium]hexane dibromide, m.p. 208-209°C.

Eksempel 51 Example 51

Fremgangsmåten var som i Eks. 49, men man anvendte 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin og 7,75 g (0,03 mol) 1.7- dibromheptan og fikk fremstilt 17,9 g 1,7-bis-[4-(2-etylhexylamino)-1-pyridinium]heptandibromid, smp. 219-220°C. The procedure was as in Ex. 49, but 12.4 g (0.06 mol) of 4-(2-ethylhexylamino)pyridine and 7.75 g (0.03 mol) of 1,7-dibromoheptane were used and 17.9 g of 1,7-bis- [4-(2-ethylhexylamino)-1-pyridinium]heptanedibromide, m.p. 219-220°C.

Eksempel 52 Example 52

Fremgangsmåten var som angitt i Eks. 49, men man anvendte 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin og 8,2 g (0,03 mol) 1,8-dibromoktan og fikk fremstilt 15,9 g 1,8-bis-[4-(2-etylhexylamino)-1-pyridinium]oktandibromid, smp. 160-161°C. The procedure was as stated in Ex. 49, but 12.4 g (0.06 mol) of 4-(2-ethylhexylamino)pyridine and 8.2 g (0.03 mol) of 1,8-dibromooctane were used and 15.9 g of 1,8- bis-[4-(2-ethylhexylamino)-1-pyridinium]octanedibromide, m.p. 160-161°C.

Eksempel 53 Example 53

Fremgangsmåten var som angitt i Eks. 49, men man brukte 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin og 8,6 g (0,03 mol) 1.9- dibromnonan og fikk fremstilt 15,2 g 1,9-bis-[4-(2-etyl-hexylamino) -1-pyridinium] nonandibromid, smp. 158-159°C. The procedure was as stated in Ex. 49, but 12.4 g (0.06 mol) of 4-(2-ethylhexylamino)pyridine and 8.6 g (0.03 mol) of 1,9-dibromononane were used and 15.2 g of 1,9-bis- [4-(2-ethyl-hexylamino)-1-pyridinium] nonanedibromide, m.p. 158-159°C.

Eksempel 54 Example 54

Fremgangsmåten var som angitt i Eks. 49, men man brukte 12,4 g (0,06 mol) 4-(2-etylhexylamino)pyridin og 9,0 g (0,03 mol) 1.10- dibromdecan og fikk fremstilt 17,4 g 1,10-bis-[4-(2-etyl-hexylamino)-1-pyridinium]decandibromid, smp. 16 2-163°C. The procedure was as stated in Ex. 49, but 12.4 g (0.06 mol) of 4-(2-ethylhexylamino)pyridine and 9.0 g (0.03 mol) of 1,10-dibromodecane were used and 17.4 g of 1,10-bis- [4-(2-ethylhexylamino)-1-pyridinium]decanedibromide, m.p. 16 2-163°C.

Eksempel 55 Example 55

Fremgangsmåte var som angitt i Eks. 2, men man brukte 5,0 g I, 10-bis-[4-(2-etylhexylamino)-1-pyridinium]decandibromid og fikk fremstilt 4,11 g av det tilsvarende diklorid, smp. 191-192°C. Procedure was as stated in Ex. 2, but 5.0 g of I, 10-bis-[4-(2-ethylhexylamino)-1-pyridinium] decanedibromide was used and 4.11 g of the corresponding dichloride was produced, m.p. 191-192°C.

Eksempel 56 Example 56

En omrørt varm oppløsning inneholdende 12,0 g (0,06 3 mol) 4-(heptylamino)-yridin i 100 ml acetonitril ble dråpevis satt til en oppløsning inneholdende 7,4 g (0,032 mol) 1,5-dibrompentan i 25 ml acetonitril, og den resulterende blanding ble kokt i 19 timer under tilbakeløp. Reaksjonsblandingen ble avkjølt i is, og eter ble gradvis tilsatt inntil man fikk utfelt et farveløst fast stoff. Dette ble oppsamlet ved filtrering, omkrystallisert fra acetonitril og eter og tørket i 48 timer ved 90°C/1 mm Hg, og man fikk 15,9 g 1,5-bis-[4-(hep-tylamino) -1-pyridinium]pentandibromid, smp. 153-rl54°C. A stirred hot solution containing 12.0 g (0.06 3 mol) of 4-(heptylamino)-yridine in 100 ml of acetonitrile was added dropwise to a solution containing 7.4 g (0.032 mol) of 1,5-dibromopentane in 25 ml acetonitrile, and the resulting mixture was refluxed for 19 hours. The reaction mixture was cooled in ice, and ether was gradually added until a colorless solid was precipitated. This was collected by filtration, recrystallized from acetonitrile and ether and dried for 48 hours at 90°C/1 mm Hg to give 15.9 g of 1,5-bis-[4-(hep-tylamino)-1-pyridinium ]pentane dibromide, m.p. 153-154°C.

Eksempel 57 Example 57

Man brukte fremgangsmåten fra Eks. 56, men anvendte 19,2 g (0,1 mol) 4-(heptylamino)pyridin og 12,2 g (0,05 mol) 1,6-dibromhexan og fikk fremstilt 27,5 g av et råprodukt. Omkrystallisering av en 15 g's prøve fra acetonitril og eter ga II, 45 g 1,6-bis-[4-(heptylamino)-1-pyridinium]hexandibromid, smp. 149-150°C. The procedure from Ex. 56, but used 19.2 g (0.1 mol) of 4-(heptylamino)pyridine and 12.2 g (0.05 mol) of 1,6-dibromohexane and obtained 27.5 g of a crude product. Recrystallization of a 15 g sample from acetonitrile and ether gave II, 45 g of 1,6-bis-[4-(heptylamino)-1-pyridinium]hexanedibromide, m.p. 149-150°C.

Eksempel 58 Example 58

A. En suspensjon av 24,0 g urent 1,6-bis-[4-(heptyl-amino) -1-pyridinium]hexandibromid i 500 ml vann ble gjort alkalisk med 3N vandig natriumhydroksyd og så ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Den gjenværende olje ble oppløst i metanol, og den resulterende oppløsning surgjort med metansulfonsyre og fordampet til tørr-het under redusert trykk. Resten ble gjenoppløst i metanol, behandlet med avfargende karbon, filtrert og fordampet til tørrhet under vakuum, hvorved man fikk en oljeaktig rest som ble behandlet med eter og deretter acetonitril, og dette ga 18,2 g av et gummiaktig fast stoff. Dette ble oppløst i vann, og oppløsningen gjort alkalisk med 35% vandig natriumhydroksyd og så ekstrahert med kloroform. Kloroformekstraktene ble tørket under vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Det resulterende faste stoff ble suksessivt behandlet med eter og acetonitril, oppsamlet ved filtrering og tørket, og man fikk 16,3 g av et lysebrunt fast stoff, smp. 105-108°C. Dette ble oppløst i 100 ml metanol, A. A suspension of 24.0 g of impure 1,6-bis-[4-(heptyl-amino)-1-pyridinium]hexane dibromide in 500 ml of water was made alkaline with 3N aqueous sodium hydroxide and then extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The remaining oil was dissolved in methanol, and the resulting solution acidified with methanesulfonic acid and evaporated to dryness under reduced pressure. The residue was redissolved in methanol, treated with decolorizing carbon, filtered and evaporated to dryness under vacuum to give an oily residue which was treated with ether and then acetonitrile to give 18.2 g of a gummy solid. This was dissolved in water, and the solution made alkaline with 35% aqueous sodium hydroxide and then extracted with chloroform. The chloroform extracts were dried under anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The resulting solid was successively treated with ether and acetonitrile, collected by filtration and dried to give 16.3 g of a light brown solid, m.p. 105-108°C. This was dissolved in 100 ml of methanol,

og oppløsningen surgjort med metansulfonsyre. Fordampning til tørrhet under redusert produkt ga en viskøs olje som ble oppløst i 20 ml metanol og behandlet porsjonsvis med 150 ml vann. Den resulterende suspensjon ble avkjølt i is, og det faste stoff ble oppsamlet ved filtrering og vasket med kaldt vann. Stoffet ble så utrørt i varm aceton, avkjølt, oppsamlet ved filtrering, vasket med kald aceton og så tørket i 48 timer ved 95°C/1 mm Hg, og man fikk 10,8 g av et lyst brunt fast stoff, smp. 163-165°C. Dette produkt ga en positiv kloridionetest med sølvnitrat, og et NMR-spektrum indikerte et fravær av metansulfonatgruppen. and the solution acidified with methanesulfonic acid. Evaporation to dryness under reduced product gave a viscous oil which was dissolved in 20 ml of methanol and treated portionwise with 150 ml of water. The resulting suspension was cooled in ice, and the solid was collected by filtration and washed with cold water. The material was then stirred in hot acetone, cooled, collected by filtration, washed with cold acetone and then dried for 48 hours at 95°C/1 mm Hg to give 10.8 g of a light brown solid, m.p. 163-165°C. This product gave a positive chloride ion test with silver nitrate, and an NMR spectrum indicated an absence of the methanesulfonate group.

B. En suspensjon av 14,0 g 1,6-bis-[4-(heptylamino)-1-pyridinium]hexandibromid i 500 ml vann ble gjort alkalisk med 35% vandig natriumhydroksyd og så ekstrahert med kloroform. Kloroformekstraktene ble tørket over vannfritt natriumsulfat og fordampet til tørrhet under redusert trykk. Den delvis faste rest ble oppløst i 1 liter acetonitril-benzen, og opp-løsningen ble fordampet til tørrhet under vakuum. Denne fremgangsmåte ble gjentatt tre ganger. Den endelige rest ble opp-løst i 50 ml acetonitril, og den resulterende oppløsning ble fortynnet med 50 ml benzen og avkjølt i is, og etter filtrering fikk man 5,3 g av et svakt brunt stoff. Filtratet ga et nytt utbytte på 4,8 g; De samlede utbytter ble kombinert og oppløst i 50 ml acetonitril. Fortynning med eter utfelte et fast stoff som ble frafiltrert og tørket i 48 timer ved 95°C/1 mm Hg, hvorved man fikk 8,85 g av et lysebrunt stoff, smp. 174-176°C. Også dette produkt ga en positiv kloridionetest med sølvnitrat. C. Produktene fra delene A og B ovenfor ble kombinert, blandet med 300 ml vann og oppvarmet inntil man fikk en homogen oppløsning. Oppløsningen ble frafiltrert, og filtratet ble behandlet med 50 ml 12N saltsyre. Den resulterende suspensjon ble konsentrert under redusert trykk, og resten ble behandlet med is. Det faste produkt ble oppsamlet ved filtrering, B. A suspension of 14.0 g of 1,6-bis-[4-(heptylamino)-1-pyridinium]hexane dibromide in 500 ml of water was made alkaline with 35% aqueous sodium hydroxide and then extracted with chloroform. The chloroform extracts were dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure. The partially solid residue was dissolved in 1 liter of acetonitrile-benzene, and the solution was evaporated to dryness under vacuum. This procedure was repeated three times. The final residue was dissolved in 50 ml of acetonitrile, and the resulting solution was diluted with 50 ml of benzene and cooled in ice, and after filtration, 5.3 g of a faint brown substance was obtained. The filtrate gave another yield of 4.8 g; The combined yields were combined and dissolved in 50 ml of acetonitrile. Dilution with ether precipitated a solid which was filtered off and dried for 48 hours at 95°C/1 mm Hg to give 8.85 g of a light brown substance, m.p. 174-176°C. This product also gave a positive chloride ion test with silver nitrate. C. The products from parts A and B above were combined, mixed with 300 ml of water and heated until a homogeneous solution was obtained. The solution was filtered off, and the filtrate was treated with 50 ml of 12N hydrochloric acid. The resulting suspension was concentrated under reduced pressure and the residue was treated with ice. The solid product was collected by filtration,

vasket med kaldt vann og tørket. Produktet ble så oppløst i aceton, oppløsningen ble fortynnet med en blanding av benzen og etanol og det hele ble fordampet til tørrhet under vakuum. Den faste rest ble utsuspendert i 100 ml aceton og så fortynnet med eter og filtrert, hvoretter man fikk etter tørking i 48 timer ved 105°C og 1 mm Hg og 72 timer ved 115°C og 1 mm Hg, ialt 16,3 g av et urent 1,6-bis-[4-(heptylamino)-1-pyridinium]-hexandiklorid som et hvitt,fast stoff, smp. 176-178°C. washed with cold water and dried. The product was then dissolved in acetone, the solution was diluted with a mixture of benzene and ethanol and the whole was evaporated to dryness under vacuum. The solid residue was suspended in 100 ml of acetone and then diluted with ether and filtered, whereupon after drying for 48 hours at 105°C and 1 mm Hg and 72 hours at 115°C and 1 mm Hg, a total of 16.3 g was obtained of an impure 1,6-bis-[4-(heptylamino)-1-pyridinium]-hexane dichloride as a white solid, m.p. 176-178°C.

Eksempel 59 Example 59

Man brukte fremgangsmåten fra Eks. 56, men anvendte 10,30 g (0,050 mol) 4-(2-etylhexylamino)pyridin og 5,4 g (0,025 mol) 1,4-dibrombutan og fikk ialt 14,9 g 1,4-bis-[4-(2-etylhexyl-amino )-1-pyridinium]butandibromid, smp. 245-246°C. The procedure from Ex. 56, but used 10.30 g (0.050 mol) 4-(2-ethylhexylamino)pyridine and 5.4 g (0.025 mol) 1,4-dibromobutane and obtained a total of 14.9 g 1,4-bis-[4- (2-ethylhexyl-amino)-1-pyridinium]butane dibromide, m.p. 245-246°C.

Eksempel 60 Example 60

A. En blanding inneholdende 229 g (1,0 mol) N-(4-pyridyl)-pyridiniumkloridhydroklorid og 244 g (1,26 mol) n-decylaminhydroklorid ble omrørt og oppvarmet i ca. 2,5 timer ved 190-195°C. Reaksjonsblandingen ble så avkjølt langsomt til 4 0°C og fortynnet med 2 1 vann. Den resulterende oppløs-ning ble avkjølt ved tilsetning av is og gjort alkalisk med 200 ml 35% vandig natriumhydroksyd. Man fikk et mørkt fast stoff,og dette ble frafiltrert og vasket med kaldt vann. Stoffet ble så oppløst i 1 liter kloroform,og oppløsningen ble behandlet med avfargende karbon og filtrert. Filtratet ble fordampet under redusert trykk, og resten ble behandlet med 150 ml eter. Det faste stoff ble gjenoppløst i kloroform, og oppløsningen ble behandlet med avfargende karbon og filtrert. Filtratet ble igjen behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under redusert trykk, og det faste stoff ble behandlet med eter. Omkrystallisering fra acetonitril ga etter tørking under vakuum 96,1 g 4-(decylamino)-pyridin, smp. 71-73°C. A. A mixture containing 229 g (1.0 mol) of N-(4-pyridyl)-pyridinium chloride hydrochloride and 244 g (1.26 mol) of n-decylamine hydrochloride was stirred and heated for approx. 2.5 hours at 190-195°C. The reaction mixture was then cooled slowly to 40°C and diluted with 2 l of water. The resulting solution was cooled by the addition of ice and made alkaline with 200 ml of 35% aqueous sodium hydroxide. A dark solid was obtained, and this was filtered off and washed with cold water. The substance was then dissolved in 1 liter of chloroform, and the solution was treated with decolorizing carbon and filtered. The filtrate was evaporated under reduced pressure and the residue was treated with 150 ml of ether. The solid was redissolved in chloroform, and the solution was treated with decolorizing carbon and filtered. The filtrate was again treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under reduced pressure and the solid was treated with ether. Recrystallization from acetonitrile gave, after drying under vacuum, 96.1 g of 4-(decylamino)-pyridine, m.p. 71-73°C.

B. En omrørt varm oppløsning inneholdende 12,2 g (0,052 mol) 4-(decylamino)pyridin i 150-170 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 6,35 g (0,026 mol) av 1,6-dibromhexan i 60 ml acetonitril, og den resulterende blanding oppvarmes i ca. 20 timer under tilbakeløp. Reaksjonsblandingen ble så avkjølt i is, og det utfelté faste stoff ble oppsamlet ved filtrering og vasket med kald acetonitril. Det oppnådde produkt ble oppløst i metanol, og den resulterende oppløsning ble behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under redusert trykk, og resten ble behandlet med 50 ml kald eter, oppsamlet ved filtrering og tørket i 2 døgn over fosforpentoksyd ved 70°C og 0,1 mm Hg. Dette ga 14,6 g 1,6-bis-[4-(decylamino)-1-pyri-dinium] hexandibromid, smp. 138-140°C. B. A stirred hot solution containing 12.2 g (0.052 mol) of 4-(decylamino)pyridine in 150-170 mL of acetonitrile was added dropwise to a solution containing 6.35 g (0.026 mol) of 1,6-dibromohexane in 60 mL acetonitrile, and the resulting mixture is heated for approx. 20 hours during reflux. The reaction mixture was then cooled in ice, and the precipitated solid was collected by filtration and washed with cold acetonitrile. The product obtained was dissolved in methanol, and the resulting solution was treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under reduced pressure, and the residue was treated with 50 ml of cold ether, collected by filtration and dried for 2 days over phosphorus pentoxide at 70°C and 0.1 mm Hg. This gave 14.6 g of 1,6-bis-[4-(decylamino)-1-pyridinium] hexanedibromide, m.p. 138-140°C.

Eksempel 61 Example 61

Man brukte fremgangsmåten fra Eks. 6OB, men anvendte 12,2 g (0,052 mol) 4-(decylamino)pyridin og 6,7 g (0,026 mol) 1,7-dibromheptan og oppnådde 16,0 g 1,7-bis-[4-(decylamino)-1-pyridinium]heptandibromid, smp. 145-147°C. The procedure from Ex. 6OB, but used 12.2 g (0.052 mol) of 4-(decylamino)pyridine and 6.7 g (0.026 mol) of 1,7-dibromoheptane and obtained 16.0 g of 1,7-bis-[4-(decylamino) -1-pyridinium]heptanedibromide, m.p. 145-147°C.

Eksempel 6 2 Example 6 2

Fremgangsmåten var som angitt i Eks. 60B, men man brukte The procedure was as stated in Ex. 60B, but one used

11,7 g (0,050 mol) 4-(decylamino)pyridin og 6,8 g (0,025 mol) 1,8-dibromoktan og oppnådde 16,9 g 1,8-bis-[4-(decylamino)-1-pyridinium]oktandibromid, smp. 180-182°C. 11.7 g (0.050 mol) 4-(decylamino)pyridine and 6.8 g (0.025 mol) 1,8-dibromooctane and obtained 16.9 g 1,8-bis-[4-(decylamino)-1-pyridinium ]octanedibromide, m.p. 180-182°C.

Eksempel 6 3 Example 6 3

Fremgangsmåten var som i Eks. 60B, men man brukte 11/7 g (0,050 mol) 4-(decylamino)pyridin og 7,15 g (0,025 mol) 1.9- dibromnonan og oppnådde 15,1 g 1,9-bis-[4-(decylamino)-1-pyridinium]nonandibromid, smp. 124-126°C. The procedure was as in Ex. 60B, but 11/7 g (0.050 mol) of 4-(decylamino)pyridine and 7.15 g (0.025 mol) of 1,9-dibromononane were used and 15.1 g of 1,9-bis-[4-(decylamino)- 1-pyridinium]nonanedibromide, m.p. 124-126°C.

Eksempel 64 Example 64

Fremgangsmåten var som beskrevet i Eks. 6OB, men man brukte 11,2 g (0,048 mol) 4-(decylamino)pyridin og 7,2 g (0,024 mol) 1.10- dibromdecan og oppnådde 14,6 g 1,10-bis-[4-(decylamino)-1-pyridinium]decandibromid, smp. 173-174°C. The procedure was as described in Ex. 6OB, but 11.2 g (0.048 mol) of 4-(decylamino)pyridine and 7.2 g (0.024 mol) of 1,10-dibromodecane were used and 14.6 g of 1,10-bis-[4-(decylamino)- 1-pyridinium]decanedibromide, m.p. 173-174°C.

Eksempel 65 Example 65

Fremgangsmåten var som angitt i Eks. 6OB, men man brukte The procedure was as stated in Ex. 6OB, but one used

11,2 g (0,048 mol) 4-(decylamino)pyridin og 7,9 g (0,024 mol) 1,12-dibromdodecan og oppnådde 16,5 g 1,12-bis-[4-(decylamino)-1-pyridinium]dodecandibromid, smp. 102-106°C. 11.2 g (0.048 mol) 4-(decylamino)pyridine and 7.9 g (0.024 mol) 1,12-dibromododecane and obtained 16.5 g 1,12-bis-[4-(decylamino)-1-pyridinium ]dodecane dibromide, m.p. 102-106°C.

Eksempel 66 Example 66

En omrørt varm oppløsning inneholdende 13,6 g (0,052 mol) 4-(dodecylamino)pyridin i 140 ml acetonitril ble dråpevis tilsatt en oppløsning inneholdende 6,34 g (0,026 mol) 1,6-dibromhexan i 50 ml acetonitril, og den resulterende blanding ble kokt under tilbakeløp over natten. Blandingen ble avkjølt, og det faste stoff ble oppsamlet ved filtrering. Det samlede faste stoff ble oppløst i absolutt etanol, og oppløsningen ble behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under vakuum, og man fikk et hvitt,fast stoff som ble utrørt i eter, frafiltrert og tørket ved 60°C/ 0,1 mm Hg, og dette ga 17,63 g 1,6-bis-[4-(dodecylamino)-1-pyridinium]hexandibromid, smp. 164-165°C. A stirred hot solution containing 13.6 g (0.052 mol) of 4-(dodecylamino)pyridine in 140 ml of acetonitrile was added dropwise to a solution containing 6.34 g (0.026 mol) of 1,6-dibromohexane in 50 ml of acetonitrile, and the resulting mixture was refluxed overnight. The mixture was cooled and the solid was collected by filtration. The combined solid was dissolved in absolute ethanol, and the solution was treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under vacuum, and a white solid was obtained which was stirred in ether, filtered off and dried at 60°C/ 0.1 mm Hg, and this gave 17.63 g of 1,6-bis-[ 4-(dodecylamino)-1-pyridinium]hexane dibromide, m.p. 164-165°C.

Eksempel 67 Example 67

Man brukte fremgangsmåten fra Eks. 66, men anvendte 13,6 g (0,052 mol) 4-(dodecylamino)pyridin og 6,71 g (0,026 mol) 1,7-dibromheptan og oppnådde 18,03 g 1,7-bis-[4-(dodecylamino)-1-pyridinium]heptandibromid, smp. 148-150°C. The procedure from Ex. 66, but used 13.6 g (0.052 mol) of 4-(dodecylamino)pyridine and 6.71 g (0.026 mol) of 1,7-dibromoheptane and obtained 18.03 g of 1,7-bis-[4-(dodecylamino) -1-pyridinium]heptanedibromide, m.p. 148-150°C.

Eksempel 68 Example 68

Fremgangsmåten var som angitt i Eks. 66, men man anvendte The procedure was as indicated in Ex. 66, but one applied

12,5 9 g (0,048 mol) 4-(dodecylamino)pyridin og 6,53 g (0,024 mol) 1,8-dibromoktan, og oppnådde 16,18 g 1,8-bis-[4-(dodecyl-amino) -1-pyridinium] oktandibromid, smp. 184-185°C. 12.59 g (0.048 mol) of 4-(dodecylamino)pyridine and 6.53 g (0.024 mol) of 1,8-dibromooctane, obtaining 16.18 g of 1,8-bis-[4-(dodecyl-amino) -1-pyridinium] octandibromide, m.p. 184-185°C.

Eksempel 69 Example 69

Fremgangsmåten var som angitt i Eks. 66, men man brukte The procedure was as stated in Ex. 66, but one used

12,59 g (0,048 mol) 4-(dodecylamino)pyridin og 6,86 g (0,024 mol) 1, 9-dibromnonan og oppnådde 19,35 g 1, 9-»bis-[4-(dodecyl-amino)-1-pyridinium] nonandibromid, smp. 134-135°C. 12.59 g (0.048 mol) of 4-(dodecylamino)pyridine and 6.86 g (0.024 mol) of 1,9-dibromononane and obtained 19.35 g of 1,9-»bis-[4-(dodecyl-amino)- 1-pyridinium] nonandibromide, m.p. 134-135°C.

Eksempel 70 Example 70

Fremgangsmåten var som angitt i Eks. 66, men man brukte 12,59 g (0,048 mol) 4-(dodecylamino)pyridin og 7,2 g (0,024 mol) 1,10-dibromdecan og oppnådde 18,08 g 1,10-bis-[4-(dodecylamino)-1-pyridinium]decandibromid, smp. 17 8-180°C. The procedure was as stated in Ex. 66, but 12.59 g (0.048 mol) of 4-(dodecylamino)pyridine and 7.2 g (0.024 mol) of 1,10-dibromodecane were used and 18.08 g of 1,10-bis-[4-(dodecylamino) )-1-pyridinium]decanedibromide, m.p. 17 8-180°C.

Eksempel 71 Example 71

Fremgangsmåten var som i Eks. 66, men man brukte 11,5 4 g The procedure was as in Ex. 66, but 11.5 4 g was used

(0,044 mol) 4-(dodecylamino)pyridin og 7,22 g (0,022 mol) 1,12-dibromdodecan og oppnådde 17,68 g 1,12-bis-[4-(dodecyl-amino) -1-pyridinium] dodecandibromid, smp. 75-77°C. (0.044 mol) 4-(dodecylamino)pyridine and 7.22 g (0.022 mol) 1,12-dibromododecane and obtained 17.68 g 1,12-bis-[4-(dodecyl-amino)-1-pyridinium] dodecane dibromide , m.p. 75-77°C.

Eksempel 72 Example 72

A. En omrørt varm oppløsning inneholdende 21,0 g (0,10 2 mol) 4-(p-klorfenylamino)pyridin i 200 ml N,N-dimetyl-formamid ble dråpevis tilsatt en oppløsning inneholdende 12,45 g (0,051 mol) 1,6-dibromhexan i 50 ml acetonitril, og den resulterende blanding ble oppvarmet i 4 timer på et dampbad- Ved avkjøling til romtemperatur fikk man utfelt et faststoff. Blandingen ble fortynnet med 150 ml acetonitril og ytterligere avkjølt på is. Det faste stoff ble frafiltrert og luft-tørket, og man fikk 27,2 g 1,6-bis-[4-(p-klorfenylamino)-1-pyri-dinium] hexandibromid, smp. 148-150°C. A. A stirred hot solution containing 21.0 g (0.10 2 mol) of 4-(p-chlorophenylamino)pyridine in 200 ml of N,N-dimethylformamide was added dropwise to a solution containing 12.45 g (0.051 mol) 1,6-dibromohexane in 50 ml of acetonitrile, and the resulting mixture was heated for 4 hours on a steam bath. On cooling to room temperature, a solid was precipitated. The mixture was diluted with 150 ml of acetonitrile and further cooled on ice. The solid was filtered off and air-dried, and 27.2 g of 1,6-bis-[4-(p-chlorophenylamino)-1-pyridinium] hexane dibromide was obtained, m.p. 148-150°C.

B. En metanoloppløsning av den tilsvarende anhydrobase ble surgjort med en metansulfonsyre og fordampet til tørrhet under vakuum. Den gjenværende olje ble utkrystallisert fra aceton og metanol og etter tørking i 48 timer ved 75°C/ B. A methanol solution of the corresponding anhydrobase was acidified with a methanesulfonic acid and evaporated to dryness under vacuum. The remaining oil was crystallized from acetone and methanol and after drying for 48 hours at 75°C/

0,1 mm Hg, ialt 25,2 g 1,6-bis-[4-(p-klorfenylamino)-1-pyri-dinium] hexandimetansulfonat, smp. 108-110°C. 0.1 mm Hg, a total of 25.2 g of 1,6-bis-[4-(p-chlorophenylamino)-1-pyridinium] hexanedimethanesulfonate, m.p. 108-110°C.

i in

Eksempel 73 Example 73

A. En omrørt varm oppløsning inneholdende 21,0 g (0,102 mol) 4-(p-klorfenylamino)pyridin i 200 ml N,N-dimetyl-formamid ble dråpevis tilsatt en oppløsning inneholdende 13,9 g (0,051 mol) 1,8-dibromoktan i 50 ml acetonitril, og den resulterende blanding ble oppvarmet i ialt 1,5 time på et dampbad. Reaksjonsblandingen ble så fortynnet med 100 ml acetonitril, A. A stirred hot solution containing 21.0 g (0.102 mol) 4-(p-chlorophenylamino)pyridine in 200 mL N,N-dimethylformamide was added dropwise to a solution containing 13.9 g (0.051 mol) 1.8 -dibromooctane in 50 ml of acetonitrile, and the resulting mixture was heated for a total of 1.5 hours on a steam bath. The reaction mixture was then diluted with 100 ml of acetonitrile,

og oppvarmingen fortsatte ytterligere 2,5 timer, da man tilsatte 100 ml acetonitril. Etter nye oppvarming i 2 timer ble blandingen avkjølt, og det faste stoff som hadde utfelt seg ble frafiltrert, vasket med en blanding av acetonitril og eter og tørket, og man fikk 30,1 g 1,8-bis-[4-(p-klorfenylamino)-1-pyridinium]oktandibromid, smp. 245-247°C. and heating was continued for a further 2.5 hours, when 100 ml of acetonitrile was added. After heating again for 2 hours, the mixture was cooled, and the solid which had precipitated was filtered off, washed with a mixture of acetonitrile and ether and dried, and 30.1 g of 1,8-bis-[4-(p -chlorophenylamino)-1-pyridinium]octane dibromide, m.p. 245-247°C.

i in

B. En metanoloppløsning av den tilsvarende anhydrobase ble surgjort med metansulfonsyre og så fordampet til tørrhet under vakuum. Den gjenværende olje ble oppløst i acetonitril, og oppløsningen ble behandlet med aceton inntil den ble uklar fulgt av en klargjøring med en liten mengde metanol og så ble den avkjølt. Det faste stoff som utfelte seg, ble oppsamlet og omkrystallisert fra acetonitril og aceton og ga etter tørking i 36 timer ved 80°C og 0,1 mm Hg, ialt 23,5 g 1,8-bis-[4-(p-klorfenylamino)-1-pyridinium]oktandimetansulfonat, smp. 164-165°C. B. A methanol solution of the corresponding anhydrobase was acidified with methanesulfonic acid and then evaporated to dryness under vacuum. The remaining oil was dissolved in acetonitrile and the solution was treated with acetone until it became cloudy followed by clarification with a small amount of methanol and then it was cooled. The solid that precipitated was collected and recrystallized from acetonitrile and acetone to give, after drying for 36 hours at 80°C and 0.1 mm Hg, a total of 23.5 g of 1,8-bis-[4-(p- chlorophenylamino)-1-pyridinium]octandimethanesulfonate, m.p. 164-165°C.

Eksempel 74 Example 74

A. En omrørt varm oppløsning inneholdende 21,0 g (0,102 mol) 4-(p-klorfenylamino)pyridin i 200 ml N,N-dimetyl-formamid ble dråpevis tilsatt en oppløsning inneholdende 15,3 g (0,051 mol) 1,10-dibromdecan i 50 ml acetonitril, og blandingen ble i 3,5 timer oppvarmet .på et dampbad. Reaksjonsblandingen ble så fordampet til tørrhet under redusert trykk, og oljen ble utkrystallisert fra metanol og acetonitril. Det faste produkt ble frafiltrert og vasket med en kald blanding av acetonitril og eter, og ga 28,0 g 1,10-bis-[4-(p-klor-fenylamino) -1-pyridinium]decandibromid, smp. 225-230°C. A. A stirred hot solution containing 21.0 g (0.102 mol) 4-(p-chlorophenylamino)pyridine in 200 mL N,N-dimethylformamide was added dropwise to a solution containing 15.3 g (0.051 mol) 1.10 -dibromodecane in 50 ml of acetonitrile, and the mixture was heated for 3.5 hours on a steam bath. The reaction mixture was then evaporated to dryness under reduced pressure, and the oil was crystallized from methanol and acetonitrile. The solid product was filtered off and washed with a cold mixture of acetonitrile and ether, yielding 28.0 g of 1,10-bis-[4-(p-chloro-phenylamino)-1-pyridinium]decanedibromide, m.p. 225-230°C.

B. En metanoloppløsning av den tilsvarende anhdro-base ble surgjort med en metansulfonsyre og fordampet til tørrhet under vakuum. Den gjenværende olje ble utkrystallisert fra acetonitril og eter. Det urene faste stoff ble oppløst i metanol, og oppløsningen ble behandlet med avfargende karbon og filtrert. Fordampning av filtratet ga en olje som ble suspendert i en blanding av acetonitril og aceton og ga et urent fast stoff. Omkrystallisering fra metanol og eter ga etter tørking ved 48 timer ved 95°C og 0,1 mm Hg ialt 18,4 g 1,10-bis-[4-(p-klorfenylamino)-1-pyridinium]decandimetansulfo-nat, smp. 202-204°C. B. A methanol solution of the corresponding anhydrobase was acidified with a methanesulfonic acid and evaporated to dryness under vacuum. The remaining oil was crystallized from acetonitrile and ether. The crude solid was dissolved in methanol, and the solution was treated with decolorizing carbon and filtered. Evaporation of the filtrate gave an oil which was suspended in a mixture of acetonitrile and acetone to give an impure solid. Recrystallization from methanol and ether gave, after drying at 48 hours at 95°C and 0.1 mm Hg, a total of 18.4 g of 1,10-bis-[4-(p-chlorophenylamino)-1-pyridinium]decandimethanesulfonate, m.p. . 202-204°C.

Eksempel 75 Example 75

En omrørt varm oppløsning inneholdende 10,0 g (0,049 mol) 4-(p-klorfenylamino)pyridin i en blanding av 125 ml N,N-di-metylformamid og 50 ml acetonitril ble dråpevis tilsatt en opp-løsning inneholdende 6,45 g 1,7-dibromheptan i 25 ml acetonitril, og blandingen ble kokt i 19 timer under tilbakeløp. Reaksjonsblandingen ble så fordampet til tørrhet under redusert trykk, og den gjenværende olje utkrystalliseres fra etanol og acetonitril. Det faste stoff ble oppløst i metanol, og oppløsningen ble behandlet med avfargende karbon og filtrert. Filtratet ble fordampet til tørrhet under vakuum, og den gjenværende olje ble igjen utkrystallisert fra etanol og acetonitril. Produktet ble frafiltrert og tørket i 36 timer ved 105°C/0,1 mm Hg, hvorved man fikk 10,4 g 1,7-bis-[4-(p-klorfenyl-amino) -1-pyridinium] heptandibromid, smp. 202-204°C. A stirred hot solution containing 10.0 g (0.049 mol) of 4-(p-chlorophenylamino)pyridine in a mixture of 125 ml of N,N-dimethylformamide and 50 ml of acetonitrile was added dropwise to a solution containing 6.45 g 1,7-dibromoheptane in 25 ml of acetonitrile, and the mixture was refluxed for 19 hours. The reaction mixture was then evaporated to dryness under reduced pressure, and the remaining oil crystallized from ethanol and acetonitrile. The solid was dissolved in methanol, and the solution was treated with decolorizing carbon and filtered. The filtrate was evaporated to dryness under vacuum, and the remaining oil was recrystallized from ethanol and acetonitrile. The product was filtered off and dried for 36 hours at 105°C/0.1 mm Hg, whereby 10.4 g of 1,7-bis-[4-(p-chlorophenyl-amino)-1-pyridinium] heptane dibromide was obtained, m.p. . 202-204°C.

Eksempel 76 Example 76

Man brukte fremgangsmåten fra Eks. 75, men man anvendte 10,0 g (0,049 mol) 4-(p-klorfenylamino)pyridin og 7;15 g (0,025 mol) 1,9-dibromnonan og oppnådde 11,2 g 1,9-bis-[4-(p-klorfenyl-amino) -1-pyridinium] nonandibromid, smp. 178-179°C. The procedure from Ex. 75, but 10.0 g (0.049 mol) of 4-(p-chlorophenylamino)pyridine and 7.15 g (0.025 mol) of 1,9-dibromononane were used and 11.2 g of 1,9-bis-[4- (p-chlorophenyl-amino)-1-pyridinium] nonan dibromide, m.p. 178-179°C.

Eksempel 77 Example 77

En omrørt varm oppløsning inneholdende 11,52 g (0,06 mol) 4-(heptylamino)pyridin i 100 ml acetonitril ble tilsatt i små mengder til en oppløsning inneholdende 7,92 g (0,03 mol) a,a<1->dibrom-p-xylen i 150 ml acetonitril. Da tilsetningen var ferdig, var det en stor masse farveløse krystaller som var utskilt fra oppløsningen. Reaksjonsblandingen ble kokt under tilbakeløp i 6 timer. Etter avkjøling til romtemperatur ble det faste produkt oppsamlet ved filtrering, vasket med acetonitril og eter og slått sammen med 3,1 g fra et tidligere forsøk, og det ble tørket i 28 timer ved 100°C/0,1 mm Hg, og dette ga 22,0 g a,a<1->bis-[4-(heptylamino)-pyridinium]-p-xylen-dibromid, smp. 297-298°C. A stirred hot solution containing 11.52 g (0.06 mol) of 4-(heptylamino)pyridine in 100 ml of acetonitrile was added in small amounts to a solution containing 7.92 g (0.03 mol) of a,a<1- >dibromo-p-xylene in 150 ml of acetonitrile. When the addition was complete, a large mass of colorless crystals separated from the solution. The reaction mixture was refluxed for 6 hours. After cooling to room temperature, the solid product was collected by filtration, washed with acetonitrile and ether, and combined with 3.1 g from a previous experiment, and it was dried for 28 hours at 100°C/0.1 mm Hg, and this gave 22.0 g of a,a<1->bis-[4-(heptylamino)-pyridinium]-p-xylene dibromide, m.p. 297-298°C.

Eksempel 78 Example 78

Man brukte fremgangsmåten fra Eks. 77, men man anvendte 11,6 g (0,065 mol) 4-(hexylamino)pyridin og 8,7 g (0,033 mol) a,a 1-bis-[4-(hexylamino)pyridinium]-p-xylendibromid, smp. 313-315°C. The procedure from Ex. 77, but 11.6 g (0.065 mol) 4-(hexylamino)pyridine and 8.7 g (0.033 mol) α,α 1-bis-[4-(hexylamino)pyridinium]-p-xylene dibromide were used, m.p. 313-315°C.

Aktivitet mot bakterier og sopp for representative eksempler av forbindelsene med formel I ble bestemt ved å bruke en modi-fikasjon av den autotiter-metode som er beskrevet av Goss, et al. Applied Microbiology 16 (9) 1,414-1,416 (1968) hvor en 1000 mcg/ml oppløsning av prøveforbindelsen ble fremstilt. Activity against bacteria and fungi for representative examples of the compounds of formula I was determined using a modification of the autotiter method described by Goss, et al. Applied Microbiology 16 (9) 1,414-1,416 (1968) where a 1000 mcg/ml solution of the test compound was prepared.

Til den første koppen i det såkalte Autotray-apparatet ble Until the first cup in the so-called Autotray device was

det tilsatt 0,1 ml av prøveoppløsningen. Aktivering av auto-titren startet ved en sekvens av operasjoner, hvor 0,05 ml av prøveforbindelsesoppløsningen ble tatt ut fra koppen ved hjelp av en mikrotiteroverføringssløyfe og fortynnet i 0,05 ml ste-rilt vann. Deretter blir 0,05 ml av et inokulert dobbeltsterkt halvsyntetisk medium (glukose) automatisk tilsatt hver kopp. Det hele resulterer i en endelig konsentrasjon som varierer fra 500 til 0,06 mcg/ml i doble økninger. Autotray-apparatet blir så inkubert i 18-20 timer ved 37°C, hvoretter de enkelte kopper blir eksaminert visuelt for vekst - noe som kan påvises ved turbiditet - og konsentrasjonen av den siste prøve i serien som ikke viser noen vekst eller ingen turbiditet, blir angitt som den minimalt hemmende konsentrasjon (MIC) i mcg/ml. Forbindelsene ble således prøvet som oppløsninger mot en rekke gram-positive og gram-negative bakterier som innbefatter Staphylococcus aureus, Proteus mirabilis, Escherichia coli, Klebsielle pneumoniae, Pseudomonas aeruginose, Streptococcus pyogenes og mot sopper som Aspergillus niger, Candida albicans og Trichophyton mentagrophytes. 0.1 ml of the sample solution was added. Activation of the auto-titer was initiated by a sequence of operations where 0.05 ml of the sample compound solution was withdrawn from the cup using a microtiter transfer loop and diluted in 0.05 ml of sterile water. Then 0.05 ml of an inoculated double-strength semi-synthetic medium (glucose) is automatically added to each cup. It all results in a final concentration ranging from 500 to 0.06 mcg/ml in double increments. The Autotray apparatus is then incubated for 18-20 hours at 37°C, after which the individual cups are examined visually for growth - which can be detected by turbidity - and the concentration of the last sample in the series which shows no growth or no turbidity, is given as the minimal inhibitory concentration (MIC) in mcg/ml. The compounds were thus tested as solutions against a number of gram-positive and gram-negative bacteria including Staphylococcus aureus, Proteus mirabilis, Escherichia coli, Klebsielle pneumoniae, Pseudomonas aeruginose, Streptococcus pyogenes and against fungi such as Aspergillus niger, Candida albicans and Trichophyton mentagrophytes.

Man fant videre at mange av forbindelsene med formel I også var effektive mot Streptococcus mutans og Actinomyces A-vis-cosis. It was further found that many of the compounds of formula I were also effective against Streptococcus mutans and Actinomyces A-vis-cosis.

Virucid aktivitet for representative eksempler mot Herpes simplex type 2-virus ble bestemt in vitro ved å bruke en fremgangsmåte som tilsvarer den plateinhiberingsprøve for påvis-ning av spesifikke hemmere av DNA-holdig virus som er publi-sert av E.C. Herrmann, Jr., Proe. Soc. Exp. Biol.Med. 107, 142 Virucidal activity of representative examples against Herpes simplex type 2 virus was determined in vitro using a method equivalent to the plate inhibition test for the detection of specific inhibitors of DNA-containing virus published by E.C. Herrmann, Jr., Proe. Soc. Exp. Biol. Med. 107, 142

(1961), hvor 2 mg av prøveforbindelsen ble plassert på over-flaten av vekstmediet. De forbindelser som tilsvarer eksemp-lene 3, 5C, 7, 9C, 10, 11, 13, 17, 18, 21, 22, 24, 31, 33, 49, 50, 51, 52, 53, 54, 56, 57, 59, 75, 76, 77 og 78 ble funnet aktive, mens forbindelsene fra Eks. 16, 39, 4 0 og 74B ble funnek å være inaktive. (1961), where 2 mg of the test compound was placed on the surface of the growth medium. The compounds corresponding to examples 3, 5C, 7, 9C, 10, 11, 13, 17, 18, 21, 22, 24, 31, 33, 49, 50, 51, 52, 53, 54, 56, 57 , 59, 75, 76, 77 and 78 were found to be active, while the compounds from Ex. 16, 39, 40 and 74B were found to be inactive.

Forskjellige data for de angitte forbindelser er angitt i den etterfølgende Tabell A. Tilsvarende data for to kjente forbindelser, nemlig 1,8-bis(4-amino-l-pyridinium)oktandi-bromid (referanseforbindelse I) og 1,10-bis-(4-amino-l-pyri-dinium) decandibromid (referanseforbindelse II) er også inklu-dert i tabell A for sammenlignende formål. Farvende konsentrasjoner for representative forbindelser er angitt i tabell C. Different data for the indicated compounds are given in the following Table A. Corresponding data for two known compounds, namely 1,8-bis(4-amino-1-pyridinium)octane bromide (reference compound I) and 1,10-bis- (4-amino-1-pyridinium) decanedibromide (reference compound II) is also included in Table A for comparative purposes. Staining concentrations for representative compounds are listed in Table C.

Antibakteriell effektivitet i nærvær av serum ble bestemt Antibacterial efficacy in the presence of serum was determined

for representative forbindelser ved en standard serierør-fortynningsprøve, hvor to og to sammenligninger av minimums-hemmende konsentrasjoner (MIC) ble bestemt i fravær og i nær- for representative compounds in a standard serial tube dilution test, where pairwise comparisons of minimum inhibitory concentrations (MICs) were determined in the absence and in the presence

i vær av varmeinaktivert (30 min. ved 56°C) hesteserum (40%) i prøvemediet. Resultatene er uttrykt som ganger økning i MIC (mcg/ml) mot Staphylococcus aureus og Escherichia coli som forårsakes av serumets nærvær, og resultatene er angitt i tabell B. in the presence of heat-inactivated (30 min. at 56°C) horse serum (40%) in the sample medium. The results are expressed as fold increase in MIC (mcg/ml) against Staphylococcus aureus and Escherichia coli caused by the presence of the serum, and the results are given in Table B.

Den akutte orale toksisitet (ALD^q) for flere representative eksempler ble bestemt på følgende måte: Grupper på 3 unge voksne hann Swiss-Webster albinomus ble fastet ca. 4 timer før tilførsel og så tilført fødeforbindelsen en gang oralt ved hjelp av et maverør. Alle mus ble observert i 7 døgn etter tilførselen. En obduksjon av lie mus som ble undersøkt viste ingen store vevsforandringer, bortsett fra den gruppen som fikk 1000 mg/kg av forbindelsen fra Eks. 25, hvor man fikk en sammensnøring av den glandulære del av maven hos to ; av de tre observerte mus. Resultatene er angitt i Tabell C The acute oral toxicity (ALD^q) for several representative examples was determined as follows: Groups of 3 young adult male Swiss-Webster albino mice were fasted approx. 4 hours before administration and then administered the food compound once orally using a stomach tube. All mice were observed for 7 days after administration. An autopsy of the mice that were examined showed no major tissue changes, except for the group that received 1000 mg/kg of the compound from Ex. 25, where a constriction of the glandular part of the stomach was obtained in two ; of the three mice observed. The results are shown in Table C

i det etterfølgende. in what follows.

Claims (2)

1. Analogifremgangsmåte for fremstilling av bis-pyridinium-alkan- og xylenforbindelser med terapeutisk aktivitet og med den generelle formel: hvor Y er en rettkjedet alkylengruppe med 4-14 karbonatomer eller en p-xylengruppe; R er en alkylgruppe med 3-12 karbonatomer, cyklohexyl eller p-klorfenyl; og A er et anion; m er 1 eller 3; n er 1 eller 2; x er 1, 2 eller 3; og (m)*(2) = (n) • (x); forutsatt at når R er p-klorfenyl, er Y en rettkjedet alkylengruppe med 6-14 karbonatomer, og når R er usubstituert cyklohexyl, er Y en alkylengruppe med 8-14 karbonatomer, karakterisert ved at man omsetter 2 mol av en 4-(R-amino)pyridinforbindelse med formelen: hvor R har den ovenfor angitte betydning, med et mol av en disubstituert alkanforbindelse med formelen: hvor Y har den ovenfor angitte betydning, og Z er klor, brom, jod, metansulfonyloksy, etansulfonyloksy, benzensulfonyloksy eller p-toluensulfonyloksyd, eller med et mol av en a,a'-disubstituert p-xylenforbindelse med formel: hvor Z har den ovenfor angitte betydning, hvor A i den resulterende forbindelse med formel I tilsvarer gruppen Z, og - om ønsket - erstatning av Z-gruppen med et annet ønsket anion av A.1. Analogous method for the preparation of bis-pyridinium-alkane and xylene compounds with therapeutic activity and with the general formula: where Y is a straight-chain alkylene group of 4-14 carbon atoms or a p-xylene group; R is an alkyl group with 3-12 carbon atoms, cyclohexyl or p-chlorophenyl; and A is an anion; m is 1 or 3; n is 1 or 2; x is 1, 2 or 3; and (m)*(2) = (n) • (x); provided that when R is p-chlorophenyl, Y is a straight-chain alkylene group of 6-14 carbon atoms, and when R is unsubstituted cyclohexyl, Y is an alkylene group of 8-14 carbon atoms, characterized by reacting 2 moles of a 4-(R -amino)pyridine compound of the formula: where R has the meaning given above, with one mole of a disubstituted alkane compound of the formula: where Y has the above meaning, and Z is chlorine, bromine, iodine, methanesulfonyloxy, ethanesulfonyloxy, benzenesulfonyloxy or p-toluenesulfonyloxide, or with one mole of an a,a'-disubstituted p-xylene compound of formula: where Z has the meaning given above, where A in the resulting compound of formula I corresponds to the group Z, and - if desired - replacement of the Z group by another desired anion of A. 2. Analogifremgangsmåte ifølge krav 1 for fremstilling av 1,10-bis-[4-(oktylamino)-1-pyridinium]dekandibromid eller -diklorid, karakterisert ved at man omsetter 2 mol av en forbindelse med formel III, hvor R er n-oktyl med et mol av en forbindelse med formel IV, hvor Y er en rettkjedet alkylengruppe med 10 karbonatomer og Z er som angitt i krav 1.2. Analogous process according to claim 1 for the production of 1,10-bis-[4-(octylamino)-1-pyridinium]decanedibromide or -dichloride, characterized in that 2 mol of a compound of formula III is reacted, where R is n- octyl with one mole of a compound of formula IV, where Y is a straight-chain alkylene group with 10 carbon atoms and Z is as stated in claim 1.
NO823274A 1976-02-25 1982-09-28 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-PYRIDINIUM ALKAN AND XYLENE COMPOUNDS NO150758C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66110176A 1976-02-25 1976-02-25
US66112876A 1976-02-25 1976-02-25
US72131576A 1976-09-07 1976-09-07
US05/734,729 US4107313A (en) 1976-02-25 1976-10-22 α,α-Bis-[4-(R-amino)-1-pyridinium]xylenes and antibacterial and antifungal uses

Publications (3)

Publication Number Publication Date
NO823274L NO823274L (en) 1977-08-26
NO150758B true NO150758B (en) 1984-09-03
NO150758C NO150758C (en) 1984-12-12

Family

ID=27505307

Family Applications (2)

Application Number Title Priority Date Filing Date
NO770631A NO148779C (en) 1976-02-25 1977-02-24 BIS-PYRIDINIUM ALKANES SUITABLE FOR USE AS DISINFECTIVES AND TO COMBAT TOOTH PLAQUE
NO823274A NO150758C (en) 1976-02-25 1982-09-28 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-PYRIDINIUM ALKAN AND XYLENE COMPOUNDS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO770631A NO148779C (en) 1976-02-25 1977-02-24 BIS-PYRIDINIUM ALKANES SUITABLE FOR USE AS DISINFECTIVES AND TO COMBAT TOOTH PLAQUE

Country Status (23)

Country Link
JP (1) JPS6033108B2 (en)
AR (2) AR214876A1 (en)
AT (1) AT355571B (en)
AU (1) AU510149B2 (en)
BE (1) BE851807A (en)
CA (1) CA1073911A (en)
CH (1) CH620907A5 (en)
DE (1) DE2708331A1 (en)
DK (1) DK147638C (en)
ES (1) ES456252A1 (en)
FI (1) FI66850C (en)
FR (1) FR2342286A1 (en)
GB (1) GB1533952A (en)
HK (1) HK67484A (en)
IE (1) IE45336B1 (en)
IL (1) IL51520A (en)
LU (1) LU76837A1 (en)
MX (1) MX5132E (en)
NL (1) NL186086C (en)
NO (2) NO148779C (en)
PH (2) PH22315A (en)
PT (1) PT66224B (en)
SE (1) SE432421B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32300E (en) * 1979-08-13 1986-12-02 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use thereof
US4420484A (en) 1979-08-13 1983-12-13 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof
DE19647413A1 (en) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides
DE19647402A1 (en) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides
DE19647317A1 (en) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides
DE10005853C1 (en) 2000-02-10 2002-02-07 Schuelke & Mayr Gmbh Process for the preparation of bis- (4-amino-1-pyridinium) alkanes
DE10205883A1 (en) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Aqueous antiseptic based on bispyridiniumalkanes
TWI278315B (en) * 2003-06-13 2007-04-11 Ind Tech Res Inst A compound having anti-virus activity
ES2237332B1 (en) * 2004-01-14 2006-11-01 Consejo Sup. Investig. Cientificas DERIVATIVES OF PIRIDINIO AND QUINOLINIO.
DE102005002645A1 (en) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Alcoholic compositions for disinfection
DE102005002644A1 (en) * 2005-01-19 2006-07-20 Schülke & Mayr GmbH Compositions for hygienic hand disinfection and disinfecting hand washing
DE102005002643B4 (en) * 2005-01-19 2007-11-22 Schülke & Mayr GmbH Compositions for hygienic hand disinfection and disinfecting hand washing
DE102005045145A1 (en) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Use of octenidine dihydrochloride in semisolid preparations
DE102005063375A1 (en) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimicrobial preparations containing octenidine dihydrochloride encapsulated in liposomes
DE102005048132A1 (en) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Process for producing antimicrobial plastic compositions
DE102005048131A1 (en) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Antimicrobial plastic composition with low elution rate and long efficacy
DE102006012991A1 (en) 2006-03-22 2007-10-11 Bayer Innovation Gmbh Method and device for optically reading information
DE102006051891A1 (en) 2006-10-31 2008-05-08 Schülke & Mayr GmbH Antimicrobial composition containing Bispyridiniumalkan
DE102008011691A1 (en) 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilized antimicrobial composition containing bispyridiniumalkane
DE102009049504A1 (en) 2009-10-15 2011-04-21 Schülke & Mayr GmbH Wound and mucous membrane antiseptic based on bispyridiniumalkanes
DE202010007433U1 (en) 2010-04-20 2011-06-01 Klosterfrau Berlin GmbH, 12277 Gel, especially lubricating gel
EP2384733B1 (en) * 2010-05-07 2016-07-27 Ivoclar Vivadent AG Antimicrobial dental materials
DE102010025932A1 (en) 2010-07-02 2012-01-05 Schülke & Mayr GmbH Antiseptic based on bispyridiniumalkanes
DE102011077432A1 (en) * 2011-06-10 2012-12-13 Schülke & Mayr GmbH Use of bispyridiniumalkanes to kill spores
DE102012215511A1 (en) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Process for the preparation of a semi-solid preparation containing bispyridiniumalkane
DE102013223657A1 (en) 2013-11-20 2015-05-21 Schülke & Mayr GmbH Kit for the production of Bispyridiniumalkan containing foams
DE102014107412A1 (en) 2014-05-26 2015-12-17 Schülke & Mayr GmbH Colored disinfecting preparation based on bispyridiniumalkane
DE102014107413A1 (en) 2014-05-26 2015-11-26 Schülke & Mayr GmbH Kit for coloring of disinfected areas of a surface
DE102014115080A1 (en) 2014-10-16 2016-04-21 Schülke & Mayr GmbH Use of fatty acid esters to improve the antimicrobial effectiveness of an alcoholic disinfectant
WO2019038669A1 (en) * 2017-08-21 2019-02-28 Dishman Carbogen Amcis Ltd. Octenidine based compounds
EP3771338A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Acidic antimicrobial composition
EP3771770A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial freshening compositions
EP3771741A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Fabric treatment
EP3771339A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Disinfectant composition
EP3771337A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial composition
EP3816272B1 (en) 2019-10-31 2023-11-01 The Procter & Gamble Company Fabric care composition
CN114989076A (en) * 2022-06-07 2022-09-02 八叶草健康产业研究院(厦门)有限公司 Preparation method of octenidine base

Also Published As

Publication number Publication date
PT66224A (en) 1977-03-01
IE45336B1 (en) 1982-08-11
NO770631L (en) 1977-08-26
DK147638C (en) 1985-07-15
FI770593A (en) 1977-08-26
ES456252A1 (en) 1978-02-01
JPS52105228A (en) 1977-09-03
PH22315A (en) 1988-07-29
PT66224B (en) 1978-07-14
DK81277A (en) 1977-08-26
AT355571B (en) 1980-03-10
NO148779C (en) 1983-12-14
CA1073911A (en) 1980-03-18
AR218052A1 (en) 1980-05-15
NL186086C (en) 1990-09-17
IL51520A0 (en) 1977-04-29
BE851807A (en) 1977-08-25
AU510149B2 (en) 1980-06-12
FI66850C (en) 1984-12-10
LU76837A1 (en) 1977-09-12
DE2708331A1 (en) 1977-09-08
NO148779B (en) 1983-09-05
FR2342286B1 (en) 1979-03-09
IL51520A (en) 1980-12-31
ATA129777A (en) 1979-08-15
JPS6033108B2 (en) 1985-08-01
HK67484A (en) 1984-09-07
NO150758C (en) 1984-12-12
FR2342286A1 (en) 1977-09-23
DK147638B (en) 1984-10-29
IE45336L (en) 1977-08-25
NO823274L (en) 1977-08-26
DE2708331C2 (en) 1991-03-21
NL186086B (en) 1990-04-17
AR214876A1 (en) 1979-08-15
NL7701965A (en) 1977-08-29
CH620907A5 (en) 1980-12-31
AU2258277A (en) 1978-08-31
FI66850B (en) 1984-08-31
SE7702072L (en) 1977-10-10
PH25097A (en) 1991-02-19
SE432421B (en) 1984-04-02
MX5132E (en) 1983-03-28
GB1533952A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
NO150758B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-PYRIDINIUM ALKAN AND XYLENE COMPOUNDS
US4206215A (en) Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
JPH0678208B2 (en) Method for increasing side branching, shoot emergence, flowering and yield of agricultural and horticultural crops using certain 2- (2-imidazolin-2-yl) pyridines and quinolines
US4563467A (en) Derivatives of N-iminopyridinium betaines having anti-hypertensive and salidiuretic activity and their preparation
US3939177A (en) 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) 1,2,3,4-Tetrahydrocarbazoles
CN114751885B (en) Coumarin compound containing isopropanolamine structure and preparation method and application thereof
US4107313A (en) α,α-Bis-[4-(R-amino)-1-pyridinium]xylenes and antibacterial and antifungal uses
SU1491339A3 (en) Method of producing crystalline form of monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-oxy-2n-1,2-benzothiazin-3-carboxamide
NO851066L (en) PYRIDINYL-2-PYRIMIDINAMINES SUITABLE AS CARDIOTONIC AGENTS AND PREPARING THEREOF
GB2029403A (en) Hercicidal pyridones and pyridinethiones
US3946012A (en) 6-L-dihydroxyethyl-2,4,7-trioxo-8-D-ribityl pteridine and process for producing the same
FI68394B (en) ANALOGIFICATION OF BIS-PYRIDINIUM XYLENE FRAMSTATING FOR THERAPEUTIC ANALYSIS
NO121213B (en)
KR810000932B1 (en) Process for preparing bis-pyridinium alkane
US3336325A (en) 1, 1&#39;-bis[(biscyanoloweralkyl)carbamoyl] methyl-4, 4&#39;-dihalide and 1, 1&#39;-bis[(bislow-eralkoxyloweralkyl)carbamoyl]methyl-4, 4&#39;-dihalide derivatives of bipyridine
DK147639B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF BIS-PYRIDINIUM COMPOUNDS
US4362734A (en) 2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their cardiotonic use
JPS5843987A (en) Novel dimethylphosphoramidate compound
US2930734A (en) 6-nitro-2-dichloroacetylamino benzothiazole and the use in combatting bacterial infections
Gadekar et al. Synthesis and biological activity of pyridoxine analogs
US2975186A (en) Certain haloalkylolamino pyridines
US2987519A (en) 3-alkyl-4, 4-bis (hydroxymethyl)-oxazolidines and process for the preparation thereof
US3274205A (en) Quaternary ammonium derivatives of n-alkylcarbamoylethyl compounds
US3995046A (en) Esters of 5-n-butylpyridine-2 carboxylic acid and pharmaceutical compositions containing these compounds